structur
gene
also
perhap
lack
gene
mbl
defici
due
one
three
point
mutat
gene
mbl
reduc
level
lectin
interf
protein
oligomer
children
kind
defici
level
mbl
mgl
compar
mgl
control
regardless
whether
children
homozygot
hz
heterozygot
het
relat
given
mutat
defect
appear
consist
small
babi
age
month
show
immatur
provid
immun
respons
capsular
bacteria
low
level
opsonin
incap
compens
risk
contract
infect
similar
hz
het
though
persist
throughout
life
hz
abnorm
allel
exhaust
het
frequenc
abnorm
similar
gener
popul
anomali
immunoglobulin
ig
opson
observ
respect
children
suffer
frequent
asthma
igg
subclass
defici
children
suffer
cystic
fibrosi
also
present
elev
preval
immedi
cutan
reaction
aeroallergen
although
without
primari
defect
adopt
immun
suscept
sever
rri
therefor
may
possibl
suffer
mucos
antigen
exclus
unlik
asthmat
children
rel
high
concentr
ige
respiratori
virus
observ
posit
skin
prick
test
spt
common
aspergillu
fumigatu
hypothesi
suggest
observ
atopi
deriv
unbalanc
immun
respons
foreign
antigen
consequ
lack
earli
identif
capac
neutral
elimin
hypothesi
base
evid
id
preced
develop
atopi
taylor
et
al
studi
newborn
babi
children
andor
sibl
atop
patient
present
signific
reduct
serum
concentr
iga
age
month
transient
hypogammaglobulinemia
hgg
infanc
thi
associ
low
iga
level
atopi
propos
classic
prospect
studi
associ
viral
respiratori
infect
vri
onset
allerg
manifest
prove
serum
iga
level
lowest
normal
level
children
studi
data
confirm
within
primari
immunodefici
pid
consid
rare
increasingli
recogn
grow
knowledg
immunolog
field
avail
sophist
diagnost
techniqu
therapeut
modal
howev
databas
inpati
gener
hospit
condit
suggest
id
patient
test
undiagnos
pid
found
subject
test
public
first
case
agammaglobulinemia
bruton
demonstr
pid
diagnosi
first
done
laboratori
howev
pid
requir
special
immunolog
center
diagnosi
manag
larg
bodi
epidemiolog
evid
support
hypothesi
exist
close
etiopathogenet
relat
pid
atopi
particular
elev
frequenc
asthma
food
allergi
fa
atop
dermat
enter
patholog
found
variou
pid
addit
discuss
anoth
subject
certainli
interest
pseudoimmunodepress
child
recurr
respiratori
infect
rri
event
often
requir
medic
intervent
often
lead
suspicion
involv
antibodi
defici
sever
pid
tabl
atop
symptom
present
gastroenter
rhiniti
select
iga
defici
sigad
sever
ad
wiskottaldrich
syndrom
hyperig
syndrom
hige
spread
entir
bodi
allerg
manifest
also
associ
asthma
rhiniti
angioedema
variou
acquisit
indic
pid
also
opson
defici
observ
normal
popul
diseas
microorgan
phagocytosi
polymorphonuclear
pmn
leukocyt
appear
annul
patient
subject
sever
infect
support
capsular
bacteria
defici
describ
associ
sever
recurr
infantil
infect
depend
lack
mannosebind
lectin
mbl
primari
immunodefici
possibl
atopi
depend
iga
underproduct
rather
ige
hyperproduct
fig
children
level
iga
minimum
normal
level
follow
birth
age
month
greater
sever
atop
manifest
increas
cumul
incid
asthma
ad
otiti
media
effus
ome
observ
compar
control
close
link
id
atopi
confirm
symptom
similar
ad
present
form
hige
xla
xlink
agammaglobulinemia
autosom
recess
ar
ataxiatelang
chapter
primari
immunodefici
propos
patient
level
suffici
modul
ige
synthesi
tcell
level
inadequ
inhibit
ige
synthesi
result
increas
ige
synthesi
hypothesi
support
observ
omenn
syndrom
especi
hige
immunolog
phenotyp
character
quantit
qualit
reduct
cell
accompani
extrem
high
level
serum
ige
lymphocyt
subject
normal
level
ige
incap
produc
even
stimul
polyclon
activ
pwm
pokewe
mitogen
ebv
epsteinbarr
viru
patient
high
antibodi
level
spontan
synthes
cultur
sige
specif
level
pgml
also
releas
factor
capabl
increas
ige
secret
igepf
supernat
deriv
cell
patient
hige
fact
capabl
induc
vitro
preb
cell
increas
ige
product
furthermor
lymphocyt
patient
isol
basi
receptor
ige
fc
fragment
remain
cell
releas
igepf
consid
suppress
activ
human
lymphocyt
phenotyp
sige
observ
lymphocyt
abl
suppress
sige
synthesi
patient
high
antibodi
level
similarli
cell
bone
marrow
transplant
bmt
suppress
ige
product
hlacompat
recipi
studi
patient
id
associ
hyperig
suppli
use
inform
concern
ige
system
biolog
although
immun
defect
essenti
respons
ige
increas
product
sever
atop
iectasia
ata
thymic
alymphoplasia
scid
sever
combin
id
occasion
digeorg
syndrom
dg
id
hyperigm
higm
defici
select
igm
defici
biotindepend
carboxylas
defici
cgd
chronic
granulomat
diseas
primari
neutropenia
netherton
nezelof
omenn
shwachman
syndrom
form
addit
discuss
associ
gastrointestin
symptom
diarrhea
malabsorpt
xla
thi
diarrhea
dg
foodrel
allergi
sigad
also
elev
frequenc
asthma
among
secondari
id
aid
associ
ad
chap
associ
defici
cell
high
level
ige
observ
patient
hige
nezelof
syndrom
ata
diseas
known
time
tabl
experiment
studi
anim
indic
may
invers
correl
serum
ige
level
tcell
function
could
attribut
tlymphocyt
defici
atop
genet
determin
make
vulner
camp
inhibit
activ
consequ
caus
imbal
two
subclass
cell
could
lead
ige
hyperproduct
atopi
develop
howev
case
evid
relationship
defici
ige
level
allerg
symptom
serum
ige
concentr
chronic
granulomat
diseas
hyper
ige
syndrom
nezelof
syndrom
nonxlink
agammaglobulinemia
variabl
immunodefici
normal
infant
adult
data
refer
month
year
gm
geometr
mean
manifest
yet
identifi
interest
syndrom
point
view
three
syndrom
analyz
character
common
clinic
indic
earli
ad
onset
increas
suscept
varieti
pathogen
well
except
high
ige
serum
level
tabl
sever
pid
autoimmun
featur
includ
syndrom
cgd
complement
defici
griscelli
syndrom
higm
defici
lad
leukocyt
adhes
defici
hla
class
defici
hla
class
ii
defici
omenn
syndrom
xlp
dealt
subsequ
children
mean
age
month
autoimmun
chronic
sever
requir
prolong
immunosuppress
howev
spontan
remiss
manifest
definit
pid
fig
consist
heterogen
spectrum
congenit
individu
combin
anomali
immun
system
humor
defici
combin
defici
b
cell
complement
phagocyt
neutrophil
etc
well
syndrom
diseas
associ
id
tradit
classifi
pid
updat
classif
tabl
divid
pid
six
main
group
also
includ
secondari
id
infect
first
among
aid
caus
defici
immunosuppress
classif
pid
base
characterist
clinic
featur
specif
alter
immun
statu
advanc
molecular
genet
make
possibl
complet
tabl
accord
type
genet
alter
molecul
involv
complet
data
see
tabl
tabl
show
behavior
antibodi
circul
b
cell
pid
occur
infrequ
highli
heterogen
natur
rel
center
gain
extens
experi
diagnosi
difficult
estim
preval
disord
routin
collect
health
statist
studi
countri
contin
includ
patient
tabl
data
concern
incid
increas
consider
thank
greater
avail
specif
test
widespread
knowledg
medic
profess
relat
pid
includ
ata
howev
primari
immunodefici
data
omenn
syndrom
ada
adenosin
deaminas
id
immunodefici
jak
janusfamili
kinas
pnp
purin
nucleosid
phosphorylas
decreas
markedli
decreas
increas
absent
present
n
normal
progress
b
function
predominantli
tcell
defect
total
may
correspond
sum
case
may
includ
pid
low
incid
figur
divid
year
consid
incid
live
birth
thi
figur
includ
probabl
case
thi
select
igg
subclass
defici
autosom
hyperigm
syndrom
select
antibodi
defici
normal
ig
cellular
antibodi
id
syndrom
associ
major
defect
ata
wasp
syndrom
digeorg
anomali
hie
nijmegen
anomali
immunodefici
associ
secondari
granulocyt
dysfunct
defect
phagocyt
number
function
cgd
cyclic
neutropenia
kostmann
syndrom
schwachman
syndrom
complement
defici
undefin
total
pid
time
period
year
year
latin
america
includ
eight
countri
xla
xlink
agammaglobulinemia
cvid
common
variabl
immun
defici
thi
transient
hypogammaglobulinemia
infanc
scid
sever
combin
id
wiskottaldrich
syndrom
ata
ataxiatelangiectasia
cgd
chronic
granulomat
diseas
reliabl
also
use
recess
xlink
pid
identifi
cell
line
genet
defect
case
one
must
howev
properli
consid
phenomenon
mutat
render
useless
inactiv
method
prove
xla
also
scid
mutat
matern
cell
germlin
main
clinic
aspect
humor
cellular
pid
schemat
tabl
numer
pid
defici
chemotaxi
tabl
cgd
antibodi
defici
current
treatment
wait
genet
treatment
becom
avail
complic
xla
sever
btk
mutat
base
prophylact
administr
ivig
combin
quick
antibiot
treatment
infecti
episod
gene
respons
id
link
chromosom
x
recent
map
respect
chromosom
band
fig
band
short
limb
design
p
long
limb
q
tabl
possibl
thank
refin
dna
recombin
technolog
rdna
includ
dna
probe
sequenc
radiomark
dna
restrict
fragment
length
polymorph
rflp
closer
gene
segreg
rflp
lower
chanc
might
separ
recombin
phenomena
meiosi
occur
identif
defici
gene
allow
earli
diagnosi
even
prenat
necessari
gene
therapi
bmt
furthermor
observ
numer
pid
transmit
xlink
modal
allow
rel
simpl
diagnosi
male
posit
famili
histori
fh
fh
neg
xla
case
femal
present
clinic
pattern
pid
sporad
case
caus
new
mutat
carrier
identif
base
studi
immunolog
normal
femal
carrier
two
popul
b
precursor
use
xchromosom
inactiv
analysi
test
take
account
exist
possibl
gene
mutat
avail
alreadi
affect
rel
also
rel
simpl
fast
molecular
studi
follow
hypothesi
earli
stage
embryogenesi
one
two
x
chromosom
randomli
inactiv
cell
tissu
femal
embryo
persist
barr
chromatin
therefor
normal
condit
one
cell
mosaic
activ
express
patern
x
chromosom
remain
matern
x
chromosom
lioniz
fig
femal
carrier
xla
cell
mosaic
express
x
chromosom
btk
activ
form
remain
x
mutat
btk
bruton
tyrosin
kinas
mean
carrier
mother
inactiv
prefer
x
chromosom
carrier
defect
gene
b
matur
therefor
unbalanc
manner
randomli
cell
activ
occur
randomli
follow
fix
carrier
b
lymphocyt
x
carrier
normal
gene
complet
differenti
rout
precursor
express
x
chromosom
mutat
btk
matur
b
cell
remain
block
fig
xscid
studi
fix
carrier
follow
correct
lyon
hypothesi
cell
normal
activ
x
develop
normal
lymphocyt
howev
precursor
mutant
x
reach
stage
x
need
find
consequ
develop
thu
femal
carrier
one
normal
activ
x
instead
random
mixtur
cell
one
two
activ
x
inactiv
test
appear
predominantli
bcell
immunodefici
inherit
xlink
trait
male
fh
posit
pid
femal
case
also
known
support
ar
trait
classic
affect
subject
present
level
igg
mgdl
low
circul
iga
igm
b
cell
tabl
found
addit
bm
preb
lymphocyt
almost
normal
quantiti
xla
character
block
bcell
differenti
result
arrest
evolut
cell
low
level
cytoplasm
igm
high
level
surrog
light
l
chain
laterstag
b
cell
bcell
differenti
arrest
major
xla
patient
appear
homogen
approxim
pro
bcell
compart
neg
cytoplasm
igm
express
size
natur
residu
matur
bcell
popul
leaki
vari
among
patient
independ
type
btk
mutat
appear
pro
bcell
compart
composit
bone
marrow
bm
xla
patient
influenc
low
level
wildtyp
btk
mrna
contrari
cell
normal
function
number
thymu
architectur
includ
hassal
corpuscl
thymusdepend
area
spleen
lymph
node
b
lymphocyt
zone
typic
deplet
absenc
gc
plasma
cell
cortic
medullar
differenti
compar
normal
fig
absenc
adenoid
tissu
fig
intestin
lamina
show
similar
defici
even
b
cell
use
recombin
chap
bm
increas
preb
lymphocyt
without
observ
preb
cell
capabl
transcrib
translat
microgram
intracytoplasm
ic
h
chain
l
chain
thu
preb
form
microgram
chain
associ
v
h
normal
cell
produc
incomplet
chain
experiment
data
current
indic
defect
lie
xla
gene
mutat
codifi
btk
xla
gene
express
b
cell
differenti
transcrib
cell
therebi
explain
b
lymphocyt
matur
block
preb
level
fig
immedi
appear
bm
xla
howev
present
genet
heterogen
explain
mutat
btk
domain
ph
th
kinas
frequenc
proport
pertin
domain
dimens
mutat
size
ascertain
find
mutat
patient
fig
equal
gene
codifi
marker
protein
receptor
essenti
bcell
matur
develop
also
involv
fact
mani
protein
includ
btk
hm
chain
surfac
protein
crucial
bcell
differenti
studi
children
sex
xla
variou
mutat
hm
germlin
identifi
addit
delet
affect
j
h
cm
gene
gene
alter
capabl
block
h
chain
synthesi
b
lymphocyt
equival
molecular
defect
observ
infant
girl
xla
differenti
block
preced
ig
gene
rearrang
earli
preb
cell
also
socal
leaki
form
absent
b
cell
variou
antibodi
defici
attribut
individu
mutat
btk
exampl
nonkinas
domain
permit
express
normal
btk
level
howev
btk
mutat
even
detriment
b
lymphocyt
prolifer
compar
total
kinas
absenc
xla
clinic
character
onset
male
babi
month
life
also
end
year
matern
igg
passiv
protect
ceas
usual
attract
attent
due
delay
growth
mostli
recurr
sever
bacteri
infect
domin
sinus
otiti
bronchiti
although
repres
phenotyp
pictur
humor
id
confirm
separ
defici
xla
associ
ghd
map
region
x
chromosom
isol
xla
observ
hz
delet
one
c
h
gene
h
chain
ig
normal
patient
led
identif
variou
polygen
delet
concern
gene
one
isotyp
subclass
subject
lack
gene
igg
subclass
associ
iga
ige
defici
clinic
symptom
case
itali
delet
frequenc
expect
frequenc
hz
famili
produc
l
chain
k
chain
known
one
famili
molecular
base
defici
ascrib
two
differ
punctiform
mutat
one
allel
prevent
format
ss
bridg
k
h
chain
k
l
ratio
human
ig
rel
alter
observ
numer
primari
secondari
id
one
patient
known
l
chain
defici
hgg
rri
upper
lower
respiratori
tract
rotaviru
echo
virus
also
caus
sever
meningoenceph
patient
phenotyp
variabl
may
occasion
present
famili
span
three
gener
patient
median
age
year
median
age
xla
onset
month
median
age
diagnosi
year
median
diagnosi
delay
month
common
infecti
diseas
pneumonia
otiti
diarrhea
sinus
arthriti
common
chronic
infect
seen
patient
respiratori
tract
gastrointestin
tract
central
nervou
system
cn
musculoskelet
system
patient
bronchiectasi
malabsorpt
arthriti
autoimmun
tumorrel
diseas
common
complic
well
edema
contractur
etc
fig
one
must
predict
onset
bronchiectasi
interven
quickli
specif
physiotherapi
form
initi
local
later
spread
caus
respiratori
failur
older
children
adolesc
onethird
case
start
monoor
rheumatoid
arthriti
ra
caus
ureaplasma
urealyticum
steril
exud
usual
regress
follow
treatment
ivig
antipolio
vaccin
live
attenu
virus
forbidden
caus
sever
pneumonia
ten
case
xla
associ
ghd
known
addit
reduc
growth
clinic
symptom
typic
xla
though
variant
sporad
case
describ
occasion
associ
sigad
often
ata
suscept
infect
without
rri
differenti
patient
probabl
pid
low
level
igg
tabl
may
repres
delay
matur
select
defici
igg
subclass
present
three
differ
aspect
total
lack
subclass
two
sd
level
averag
inabl
produc
antibodi
rel
subclass
question
even
hemat
concentr
normal
follow
select
defici
present
isol
igg
defici
case
describ
also
subclass
repres
igg
other
account
igg
igg
igg
absenc
probabl
indic
evid
hgg
patient
usual
reduc
level
total
igg
react
normal
antigen
polysaccharid
capsul
combin
id
cid
exampl
igg
igg
igg
igg
igg
igg
igg
igg
igg
igg
igg
igg
associ
defici
iga
subclass
associ
sigad
defect
igg
subclass
explain
view
ig
product
ontogenesi
b
cell
one
start
igm
move
igd
igg
end
iga
pass
ige
therefor
defici
could
origin
immunolog
defect
involv
lymphocyt
regul
work
b
cell
secret
ig
effect
final
stage
product
rare
case
less
extend
delet
chromosom
observ
region
codifi
h
chain
case
genom
instead
intact
confirm
possibl
defect
b
lymphocyt
switch
rare
defici
depend
gene
hz
delet
pid
probabl
common
tabl
especi
nonselect
popul
caucasian
origin
defin
presenc
serum
level
iga
mgdl
absenc
siga
total
defici
partial
sigad
level
mgdl
sd
compar
normal
level
age
measur
siga
total
defici
igm
igg
level
normal
tabl
igg
igg
level
low
sever
case
partial
defici
transient
return
normal
level
iga
case
age
fig
sigad
transmit
sporad
howev
case
multifactori
domin
ar
variabl
incomplet
express
transmit
within
famili
report
function
alter
reflect
final
matur
process
b
lymphocyt
given
b
iga
lymphocyt
show
igmigdiga
membran
phenotyp
normal
aspect
newborn
babi
studi
chromosom
led
conclus
result
delet
children
sigad
associ
mental
retard
facial
dysmorph
failur
thrive
etc
associ
hla
haplotyp
situat
chromosom
instead
consist
common
patient
cvid
interest
indic
understand
pathogenesi
come
molecular
genet
studi
allow
formul
hypothesi
multifactori
origin
given
combin
wide
involv
hla
haplotyp
extend
haplotyp
involv
class
iiii
gene
extent
often
encount
gener
popul
among
class
iii
allel
studi
gene
dictat
among
class
ii
common
associ
haplotyp
haplotyp
extend
first
increas
patient
combin
iga
igg
ige
defici
associ
give
sigad
risk
factor
tabl
one
hla
supertyp
also
found
defici
late
onset
suggest
import
locu
iga
differenti
close
class
iii
hla
gene
thought
induc
sigad
nonhla
gene
environment
penetr
factor
might
necessari
due
possibl
sigad
discord
express
hlaident
twin
howev
analyz
sequenc
involv
allel
show
signific
sigad
correl
allel
belong
hladq
locu
compos
protect
allel
aspart
acid
suscept
one
valin
alanin
b
chain
posit
observ
presenc
aspart
acid
ensur
protect
dm
furthermor
immunolog
deregul
extend
typic
format
autoantibodi
character
presenc
igg
antiiga
subject
wide
symptom
rang
mostli
repres
rri
allerg
autoimmun
diseas
aid
among
diabet
allerg
diseas
twice
common
partial
defici
unlik
aid
clinic
point
view
frequenc
chronic
diarrhea
malabsorpt
associ
celiac
disord
giardia
lamblia
infest
surpris
consid
siga
promin
iga
igg
igg
ige
due
delet
ig
h
chain
constant
region
gene
associ
undu
suscept
infect
see
rri
case
select
igm
defici
known
associ
rri
variou
symptom
igm
defici
detect
four
children
rri
isol
igm
defect
present
two
children
two
children
associ
igg
subclass
defici
cvid
includ
heterogen
group
unhealthi
condit
common
hgg
rri
incid
inherit
two
suscept
gene
within
hla
short
arm
chromosom
one
locat
near
class
ii
region
near
junction
class
iii
class
region
seriou
risk
develop
cvid
autosom
domin
ar
form
also
link
sex
sporad
case
common
molecular
base
total
clarifi
yet
pathogenet
mechan
may
depend
b
lymphocyt
patient
lymphocyt
defect
bcell
intrins
defect
attribut
alter
differenti
line
differ
stage
matur
result
poor
format
antibodi
hgg
variabl
degre
patient
xla
circul
b
lymphocyt
virtual
absent
igg
mgdl
reduct
subclass
normal
phenotyp
observ
patient
often
hierarch
order
shortag
igg
igg
igg
igg
iga
igm
antibodi
mgdl
reflect
potenti
underexpress
impli
activ
defici
tb
cooper
defect
studi
lymphocyt
subpopul
indic
variou
subgroup
patient
cell
scarc
il
il
il
level
reduc
ratio
increas
bear
marker
suppress
igg
product
elabor
normal
il
level
increas
ifng
product
also
accompani
defici
interleukin
il
il
ifng
suggest
defect
signal
mechan
base
tlymphocyt
defici
therefor
difficult
evalu
also
could
vri
effect
cvid
also
observ
follow
congenit
rubella
ebv
infect
also
induc
drug
phenytoin
cvid
famili
subject
identifi
ident
larg
mutat
ico
induc
costimul
gene
express
surfac
role
format
barrier
penetr
polypeptid
macromolecul
intestin
mucosa
sigad
therefor
facilit
penetr
food
antigen
mucosa
follow
format
specif
antibodi
exampl
patient
present
cic
precipitin
cm
bovin
antiserum
antiserum
calf
fetu
symptom
affect
respiratori
tract
also
caus
absenc
siga
children
age
increas
suscept
rri
patient
balanc
siga
defici
sigm
case
compens
insuffici
exempt
rri
asthma
sigad
diagnos
basi
serum
secretori
iga
normal
level
adult
achiev
differ
time
tabl
drug
phenytoin
anticonvuls
determin
sigad
sometim
persist
time
drug
discontinu
clinic
symptom
case
differ
patient
sigad
random
treatment
patient
benefit
therapi
ivig
even
enrich
iga
counterind
obligatori
option
vaccin
whole
blood
plasma
transfus
contain
iga
sensit
patient
caus
anaphylact
shock
alreadi
sensit
life
expect
excel
howev
random
discoveri
sigad
asymptomat
children
underestim
fact
undergo
period
clinic
laboratori
control
identifi
earli
possibl
possibl
pertin
symptom
time
need
ensur
good
life
qualiti
adequ
prevent
rri
patient
whose
respiratori
tract
affect
sadni
translat
inabl
respond
certain
antigen
especi
polysaccharid
individu
normal
other
contract
sinopulmonari
infect
reduct
igg
level
associ
relationship
random
one
igg
level
hand
predict
antibodi
respons
subject
respond
antihepat
vaccin
may
fall
categori
one
retrospect
survey
pediatr
tertiari
care
center
sadni
frequent
diagnosi
account
id
diagnos
case
patient
good
health
without
ige
due
gene
delet
two
sibl
defici
activ
cell
interact
ico
ligand
gene
express
b
cell
addit
patient
sporad
cvid
examin
mutat
found
patient
cvid
screen
thu
far
found
ico
mutat
one
unexplain
featur
cvid
onset
clinic
symptom
occur
late
childhood
adulthood
pid
variabl
either
clinic
immunolog
pattern
onset
period
common
school
year
adult
also
age
acut
bacteri
recurr
andor
sever
lower
respiratori
tract
infect
lrti
characterist
sinus
pediatr
case
otiti
media
bronchiti
pneumonia
andor
digest
tract
infect
diarrhea
preval
infect
caus
mycet
increas
well
case
pneumonia
caus
pneumocysti
carinii
signal
cellmedi
immun
cmi
gastroenter
tract
domin
symptom
similar
seen
celiac
diseas
gener
malabsorpt
steatorrhea
lactos
intoler
proteinlos
enteropathi
inflammatori
bowel
diseas
ibd
saccharidas
defici
malabsorpt
vitamin
b
folic
acid
support
also
case
intestin
infest
caus
giardia
lamblia
tumor
necrosi
factor
receptor
famili
tnfr
member
taci
transmembran
activ
calciummodul
cyclophilin
ligand
interactor
mediat
isotyp
switch
b
cell
unrel
subject
cvid
subject
sigad
missens
mutat
one
allel
encod
taci
none
mutat
present
healthi
subject
mutat
cosegreg
phenotyp
cvid
sigad
famili
member
index
subject
b
cell
subject
taci
mutat
express
taci
produc
igg
iga
respons
taci
ligand
april
proliferationinduc
ligand
probabl
reflect
impair
isotyp
switch
characterist
hemopathi
hepatosplenomegali
autoimmun
hemolyt
anemia
aiha
xlink
lymphoprolif
diseas
xlp
cutan
intern
organ
granuloma
differenti
xla
particular
ra
thrombocytopenia
neutropenia
offspr
cvid
patient
risk
throughout
live
cvid
develop
monitor
high
index
suspicion
base
experiment
evid
hypothes
igaand
cvidassoci
defici
may
extrem
opposit
one
clinic
spectrum
block
bcell
differenti
differ
isotyp
involv
defect
often
appear
differ
member
famili
group
less
allel
present
accredit
hypothesi
number
extend
haplotyp
hla
system
share
gene
duplic
delet
polymorph
codifi
class
ii
iii
allel
correspond
fact
number
common
hla
haplotyp
especi
belong
class
iii
observ
patient
least
two
haplotyp
case
postul
therefor
exist
common
genet
basi
suscept
gene
possibl
associ
marker
exampl
five
member
larg
famili
one
two
pid
duplic
gene
associ
select
group
hla
class
ii
iii
gene
fact
four
member
without
pid
also
haplotyp
indic
presenc
alon
suffici
express
pid
leav
room
therefor
factor
overlap
relat
celiac
diseas
analysi
link
gene
confirm
strong
associ
locu
suggest
import
role
pid
play
gene
codifi
adjac
one
see
xlink
hyperigm
hyperigd
defici
xhigm
discuss
unlik
transient
hgg
occur
matern
igg
gradual
disappear
circul
tabl
origin
studi
taylor
et
al
iga
level
fallen
becom
regular
newborn
babi
thi
year
correspond
nonatop
level
consist
therefor
patholog
delay
normal
antibodi
product
matur
process
walker
et
al
calcul
preval
thi
children
equal
preval
symptomat
sigad
children
igg
iga
percentil
igm
level
percentil
resolv
around
month
confirm
consist
fact
children
symptom
either
ad
fa
food
intoler
tabl
mean
incid
year
children
age
month
diagnos
thi
incid
studi
main
defect
igg
one
normal
month
anoth
trial
babi
exhibit
age
month
absenc
serum
igg
level
specif
antibodi
viral
agent
eight
children
detect
serum
igg
level
return
normal
wherea
basi
il
r
defici
precis
g
receptor
map
chromosom
sole
defici
il
r
suffici
produc
immunolog
phenotyp
devast
scid
g
chain
il
r
il
rg
share
compon
il
r
il
r
il
r
il
r
il
r
il
r
il
r
gc
mutat
interf
link
il
depriv
lymphoid
progenitor
cell
crucial
signal
normal
lymphocyt
intrathym
develop
mutat
gene
il
rg
il
ra
artemi
ada
caus
scid
total
il
gene
mutat
sequenc
uniqu
mutat
result
defici
vari
degre
id
mutat
distribut
throughout
eight
exon
gene
well
region
necessari
proper
transcript
translat
penetr
il
rg
mutat
unknown
exon
mutat
hot
spot
type
mutat
identifi
includ
missens
nonsens
insert
delet
splice
mutat
mutat
affect
rna
process
translat
among
mutat
patient
numer
punctiform
mutat
fig
plu
one
missens
relat
amino
acid
residu
lack
gc
interact
atyp
form
substitut
residu
cystein
arginin
posit
appear
decis
gc
chain
express
probabl
mutat
revers
basi
molecular
defect
numer
function
tcell
normal
mutat
inactiv
common
g
chain
render
cell
boy
unrespons
sever
il
result
block
tcell
develop
sever
defici
matur
cell
b
cell
although
pretwo
children
normal
igg
level
detect
even
appear
specif
viral
antibodi
igg
level
usual
normal
month
age
year
fig
month
age
children
howev
still
low
ig
level
month
age
children
ig
level
still
sd
age
variou
igg
subclass
defici
detect
prospect
studi
followup
found
igg
iga
defici
normal
age
minor
case
may
prodrom
sigad
anoth
humor
defici
studi
followup
children
igg
defici
well
iga
defici
case
observ
multiform
clinic
symptom
sinc
thi
gradual
normal
children
low
antibodi
titer
other
low
igg
level
howev
group
experienc
signific
infect
case
thi
asymptomat
other
infect
especi
respiratori
tract
present
design
thi
may
misnom
altern
design
could
ad
thi
recoveri
develop
dysgammaglobulinemia
gener
characterist
combin
tcellbcel
immunodefici
summar
tabl
b
scid
heterogen
group
incid
livebirth
xlink
fh
posit
case
genet
sent
normal
even
increas
number
form
scid
dysfunct
b
cell
matur
produc
antibodi
due
complet
bcell
differenti
arrest
prebcr
checkpoint
show
absenc
complet
vdj
recombin
form
also
known
attenu
phenotyp
partial
tcell
function
typic
repres
common
form
case
tabl
thymu
sever
hypocellular
without
lymphocyt
hassal
bodi
thymic
epitheli
cell
predomin
without
grossli
evid
corticomedullari
differenti
fig
sever
lymphopenia
often
associ
eosinophilia
nk
cell
within
norm
rare
major
infant
lack
nk
cell
b
nkphenotyp
cell
present
matern
origin
block
also
scid
ar
occur
level
develop
cell
thymic
dc
reduc
compar
ageand
gendermatch
control
thymu
fig
pret
tn
thu
scid
b
studi
subpopul
distinguish
scid
subtyp
cell
reduc
variant
absolut
cord
blood
cb
number
lymphocytesmm
tabl
count
lymphopen
moreov
ada
defici
adenosinedeaminas
maximum
reduct
total
lymphocyt
chapter
primari
immunodefici
ali
common
nk
cell
drop
furthermor
two
cohort
affect
femal
phenotyp
indic
possibl
complex
molecular
defect
respons
delay
spt
absenc
lymphocyt
prolif
respons
mitogen
specif
antigen
tetan
toxoid
averag
age
diagnosi
month
children
similar
age
report
children
scid
caus
male
femal
ratio
diagnosi
often
miss
occur
late
save
live
infect
infant
may
manifest
gvhd
earli
morbilliform
erupt
first
day
life
due
transplacent
acquir
matern
cell
intract
diarrhea
result
sever
malabsorpt
fig
sever
interstiti
pneumonia
fig
giant
cell
caus
antimeasl
vaccin
bcg
bacillu
calmett
death
caus
chickenpox
infect
caus
pneumocysti
carinii
herp
adenoviru
cmv
cytomegaloviru
etc
absenc
tonsil
observ
also
lymphoid
tissu
thymu
hypoplasia
children
must
transfer
urgent
special
center
place
steril
room
receiv
bmt
rare
occas
il
mutat
caus
atyp
mild
scid
present
beyond
infanc
upregul
il
r
lack
il
rb
tyrosin
residu
lead
increas
cell
surviv
il
depriv
astonishingli
surviv
signal
occur
gc
tyrosin
residu
absent
thu
cienci
number
b
cell
highest
nk
cell
lowest
b
nk
nk
cell
contrari
reach
highest
level
ar
form
scid
also
b
alymphocytosi
diverg
data
howev
characterist
b
nkmolecular
defect
gc
defect
b
nk
ada
defici
b
possibl
recombin
anom
gcdepend
signal
reveal
absenc
il
rb
tyrosin
il
r
engag
least
two
distinct
signal
pathway
regul
apoptosi
express
two
clinic
seri
patient
mutat
il
rg
repres
scid
case
children
il
rg
mutat
lymphopenia
case
total
lymphocyt
count
normal
level
base
clinic
case
seri
patient
low
absent
cell
approxim
low
absent
nk
cell
ar
mutat
gene
autosom
chromosom
identifi
ada
defici
defici
rag
defici
exist
band
tlymphocyt
lymphoid
precursor
differenti
defect
particular
case
mutat
two
gene
activ
vdj
recombin
observ
howev
gene
function
question
sinc
rag
defect
present
b
scid
omenn
syndrom
babi
suffer
scid
mark
reduct
b
lymphocyt
tabl
vivo
vitro
respons
absent
onset
clinic
histolog
pattern
similar
xscid
gene
mutat
tabl
variant
frequenc
among
babi
affect
scid
absenc
nk
cell
molecular
base
mutat
affect
prevent
associ
gc
chain
send
signal
abovement
il
marker
protein
belong
jakstat
complex
origin
lack
lymphocyt
transform
scid
phenotyp
patient
present
b
nk
b
iga
equal
xscid
present
defect
differenti
capabl
produc
elev
level
ige
absenc
isotyp
data
indic
gc
essenti
tand
nkcell
develop
clinic
characterist
ident
xscid
differ
phenotyp
also
observ
femal
furthermor
defici
could
import
caus
scid
ar
consid
patient
b
nkphenotyp
without
xrecess
heritag
infant
present
histori
recurr
infect
failur
thrive
novel
splice
mutat
gcdepend
describ
character
nearnorm
count
function
defici
nk
cell
b
nkcell
phenotyp
cell
surfac
gc
express
undetect
nk
cell
trace
amount
minor
b
cell
cell
absent
igg
iga
undetect
igm
within
normal
rang
bmt
perfect
therapi
bcell
function
develop
children
nk
function
normal
children
bmt
famili
pedigre
show
inbr
famili
consanguin
across
five
gener
two
brother
diagnos
scid
one
age
month
present
persist
oral
thrush
oral
ulcer
failur
thrive
palpabl
lymph
node
thymu
shadow
chest
xray
film
second
diagnos
soon
birth
third
brother
alway
healthi
three
male
cousin
die
infanc
sever
infect
consist
scid
th
cousin
present
oral
candidiasi
age
week
failur
thrive
thymic
shadow
detect
chest
xray
film
peripher
blood
lymphocyt
show
persist
lymphopenia
lymph
node
fail
reject
skin
allograft
show
increas
blood
igg
igm
antibodi
dtp
three
vaccin
three
affect
patient
hz
caet
transit
nucleotid
exon
lead
prolin
serin
substitut
extracellular
domain
il
r
cousin
parent
harbor
wild
mutant
allel
partial
defici
suffici
block
tcell
develop
lead
scid
phenotyp
fh
sever
pid
multipl
affect
male
infant
strongli
suggest
xlink
inherit
nevertheless
famili
consanguin
favor
ar
inherit
defect
il
r
express
caus
three
patient
b
nk
scid
indic
tcell
defect
result
inactiv
il
ra
signal
thu
il
rmediat
signal
requir
cell
nk
ontogen
mutat
gene
il
r
chain
chromosom
found
three
patient
infant
resembl
type
scid
respect
suscept
infect
absenc
function
cell
b
cell
howev
differ
circul
lymphocyt
primarili
nk
cell
requir
rearrang
tcr
bcr
gene
half
patient
b
scid
mutat
gene
thu
highlight
crucial
role
gene
normal
v
j
recombin
machineri
ragthymocyt
lack
function
pretcr
henc
arrest
stage
different
without
matur
ig
tcr
gene
assembl
lymphocyt
develop
arrest
earli
stage
abnorm
chest
scapula
iliac
bone
short
stumpi
limb
xray
abnorm
document
fig
absent
thymic
shadow
notabl
cup
flare
rib
end
arrow
observ
histolog
studi
chondrocost
junction
document
total
cellular
disorgan
fig
defici
object
great
deal
attent
first
treat
use
gene
therapi
lack
ada
observ
patient
scid
ada
enzym
catalyz
convers
adenosin
deoxyadenosin
inosin
deoxynosin
although
ada
found
cell
anchor
ada
lymphocyt
cell
surfac
tabl
defici
damag
immun
system
tabl
summar
biochem
foundat
pid
ada
mutat
known
includ
amino
acid
substitut
delet
punctiform
mutat
anomali
gene
exon
delet
exon
mutat
total
nine
patient
adascid
six
partial
defici
addit
mutant
allel
found
missens
singlecodon
delet
adenosin
deoxyadenosin
also
appar
suicid
inactiv
enzym
sadenosylhomocystein
sah
hydrolas
consequ
accumul
sah
power
inhibitor
virtual
cellular
methyl
reaction
accumul
metabolit
includ
camp
deoxyatp
toxic
effect
cell
block
dna
synthesi
divid
rest
lymphocyt
prolifer
fig
four
differ
clinic
phenotyp
describ
adadefici
subject
tabl
cover
broad
spectrum
immunolog
aberr
complet
absenc
b
immun
indic
scid
patient
thymu
fig
form
delay
onset
partial
defici
children
delay
onset
symptom
diagnosi
estim
averag
month
clinic
symptom
indic
earli
onset
addit
typic
scid
symptom
also
xray
pathognomon
skelet
abnorm
chondrodysplasia
type
especi
rare
ar
type
scid
observ
first
time
ident
twin
male
infant
exhibit
total
lack
lymphocyt
granulocyt
peripher
blood
bone
marrow
frequenc
case
scid
children
symptomat
case
within
first
day
birth
usual
fatal
within
month
life
without
bmt
due
common
stem
cell
sc
nonmatur
character
total
block
lymphoid
myeloid
precursor
differenti
therefor
extraordinari
lymphopenia
also
mark
cytopenia
section
tabl
spleen
lymph
node
gastroenter
tract
high
frequenc
sever
success
infect
thymu
alway
much
reduc
volum
hassal
bodi
seen
seven
eight
infant
report
defect
die
day
age
overwhelm
infect
eighth
underw
complet
immunolog
reconstitut
bmt
addit
three
five
children
requir
two
hsct
hematopoiet
sct
stemcel
transplant
receiv
intens
condit
therapi
haploident
hsct
match
hla
loci
aliv
well
activ
phenotyp
poor
function
capac
studi
involv
hla
typif
dna
polymorph
show
cell
belong
host
rule
therefor
etiolog
matern
cell
engraft
unlik
type
scid
absenc
circul
b
also
characterist
equal
normal
level
reach
high
ige
level
uil
hypereosinophilia
reach
cellsl
normal
cellsl
low
ig
level
begin
declin
point
agammaglobulinemia
compar
reticular
digenesi
tabl
mark
bcell
deplet
also
bear
gene
missens
mutat
decreas
effici
vdj
recombin
result
impair
absent
rearrang
bcr
tcr
four
missens
mutat
detect
patient
patient
mutat
affect
gene
gene
increas
ige
link
primari
infiltr
spontan
product
il
ifng
il
il
il
downregul
ifng
therapi
clonal
expans
high
il
level
low
il
ifng
level
could
indic
analog
fa
defect
lymphocyt
show
activ
phenotyp
spontan
apoptosi
associ
reduc
express
gene
product
higher
cell
death
cell
given
high
level
lymph
node
skin
serum
three
children
gener
lymphocyt
pathogenesi
possibl
marker
chap
human
scid
b
cell
found
mice
scid
final
repertoir
decidedli
oligoclon
lack
heterogen
characterist
normal
immun
system
lymphopen
scid
omenn
syndrom
could
two
aspect
diseas
differ
clinic
express
especi
time
clinic
young
babi
soon
birth
show
gener
exud
erythroderma
desquam
often
mistaken
ad
alopecia
widespread
lymphadenopathi
hepatosplenomegali
persist
profus
diarrhea
failur
thrive
malnutrit
fig
aiha
recurr
infect
caus
common
opportunist
germ
fig
markedli
elev
serum
ige
level
outlin
includ
four
babi
famili
symptom
death
occur
month
present
hypereosinophilia
diagnos
dm
differenti
diagnosi
may
challeng
sinc
omenn
syndrom
gvhd
show
dyskeratosi
basal
vacuol
first
alway
show
acanthosi
usual
parakeratosi
gvhd
show
flat
epidermi
rare
parakeratosi
distinguish
immunohistochem
stain
show
predominantli
lymphocyt
dermal
infiltr
omenn
syndrom
rel
macrophag
gvhd
myeloid
tand
bcell
lymphoid
reconstitut
anoth
child
aliv
well
month
bscid
character
increas
cell
sensit
radiat
secondari
mutat
artemi
gene
could
carri
poorer
prognosi
defect
repair
dna
break
occur
around
time
bmt
effect
chemotherapi
infect
gvhd
one
group
patient
scid
addit
sensit
radiat
found
harbor
larg
delet
truncat
mutat
artemi
gene
map
chromosom
impli
role
artemi
dna
doublestrand
break
repair
mutat
human
scid
omenn
syndrom
classifi
scid
newborn
babi
exhibit
symptom
similar
gvhd
due
antigen
express
absenc
coexist
famili
alymphocytosi
ar
syndrom
unknown
pathogenesi
share
characterist
clinic
immunolog
abnorm
b
scid
sever
cutan
lesion
hyperkeratosi
apoptot
malpighian
necrosi
basal
membran
destruct
associ
lymphoid
cell
hassal
bodi
found
thymu
immunolog
structur
reveal
histiocyt
infiltr
skin
bm
lymph
node
prolifer
infiltr
epidermi
enter
mucosa
increas
cell
combin
tcell
bcell
defici
igg
gl
igm
gl
neutrophil
cellsml
data
child
scid
circul
cell
within
norm
gene
transcript
defici
ascertain
male
infant
first
cousin
parentag
present
age
month
cmv
pneumonia
persist
oral
esophag
candidiasi
adenoviru
gastroenter
failur
thrive
develop
lymphadenopathi
hepatosplenomegali
iron
defici
anemia
evid
hemolyt
anemia
chronic
inflamm
lung
mandibl
biopsi
show
extens
lymphocyt
infiltr
lung
liver
gut
bone
serum
igg
igm
elev
iga
low
tcell
lymphocytopenia
abnorm
ratio
cell
respond
poorli
phytohemagglutinin
mitogen
il
found
truncat
mutat
il
ra
chain
given
success
allogen
bmt
cytoreduct
case
report
xlink
form
defici
patient
gener
male
nonxlink
form
patient
femal
estim
minim
incid
calcul
live
birth
half
patient
develop
id
symptom
diagnos
year
age
year
age
although
carrier
xhigm
consid
asymptomat
extrem
lyoniz
normal
x
lead
mild
express
xhigm
similar
cvid
secondarili
caus
environment
factor
also
stem
congenit
rubella
indic
heterogen
mutat
encod
xhigm
patient
result
lack
bcell
signal
activ
cell
howev
boy
fail
express
mutat
found
boy
wherea
mutat
found
boy
weak
express
result
xmigm
b
cell
fail
undergo
isotyp
switch
produc
igm
due
defect
rna
edit
enzym
activationinduc
cytidin
deaminas
aicda
enzym
express
b
cell
requir
process
classswitch
somat
hypermut
ig
gene
mark
reduct
igg
mgdl
ige
iga
accompani
sharp
increas
matur
igm
circul
igd
b
cell
express
ig
interestingli
patient
confirm
xhigm
mutat
low
concentr
igg
iga
igm
remain
patient
xhigm
classic
pattern
normal
rais
igm
low
concentr
iga
igg
gene
defect
usual
express
membran
activ
lymphocyt
therefor
bind
bcell
figur
show
local
mutat
frequenc
case
mistakenli
exampl
sens
codon
substitut
missens
one
creat
prematur
stop
signal
therefor
specif
pertin
mutat
tunist
infect
disord
relat
mutat
gene
encod
nuclear
factor
kb
nfkb
requir
activ
transcript
factor
nfkb
nemo
nfkb
essenti
modifi
also
known
ikk
inhibitor
b
kinas
phenotyp
observ
xhigmseda
patient
show
put
zincfing
domain
nemo
regulatori
function
demonstr
definit
requir
nfkb
activ
b
cell
ig
classswitch
three
gene
express
b
cell
associ
higm
phenotyp
give
place
higm
mutat
activationinduc
cytidin
deaminas
aicda
uracil
glycosylas
ung
express
follicular
b
lymphocyt
lead
defect
class
switch
recombin
somat
hypermut
mutat
receptor
caus
rare
autosom
form
clinic
phenotyp
similar
defici
rare
pid
may
shed
light
complex
event
lead
product
highaffin
antigenspecif
antibodi
differ
isotyp
earli
treatment
ivig
associ
antibiot
prophylaxi
reduc
incid
lifethreaten
infect
improv
growth
children
higm
cycl
gcsf
granulocytecoloni
stimul
factor
presenc
sever
neutropenia
advis
substitut
therapi
solubl
form
recombin
gene
type
studi
recent
review
patient
show
develop
liver
diseas
surviv
third
decad
life
bmt
success
outcom
young
children
older
patient
adcan
interfer
directli
link
site
fig
consequ
signal
indic
b
cell
begin
isotyp
switch
limit
product
lowaffin
igm
miss
without
isotyp
switch
gc
format
minim
fig
follicular
dendrit
cell
fdc
reduc
number
also
abnorm
phenotyp
shown
fig
lack
crosslink
result
bcell
failur
upregul
import
costimulatori
molecul
interact
immunoregulatori
molecul
cell
two
patient
normal
level
also
describ
male
xla
infect
start
month
often
observ
otiti
pneumonia
sepsi
case
pyogen
bacteria
opportunist
infect
particular
caus
pneumocysti
carinii
also
ulcer
stomat
ra
neutropenia
aiha
lymphoprolifer
complic
type
b
gastroenter
lymphoma
igm
promin
clinic
infect
pneumonia
patient
upper
respiratori
infect
urti
includ
sinus
recurr
otiti
lrti
recurrentprotract
diarrhea
cn
infect
sepsi
cellul
hepat
osteomyel
lymphoid
tissu
normal
hyperplast
recent
rare
form
higm
associ
hypohydrot
ectoderm
dysplasia
eda
character
absenc
hypoplasia
hair
teeth
sweat
gland
describ
unlik
patient
higm
patient
fail
histori
oppor
purinenucleosid
phosphorylas
pnp
defici
ar
patient
report
character
absenc
enzym
necessari
catabol
purin
convert
inosin
deoxynosin
guanosin
deoxyguanosin
hypoxanthin
guanin
fig
respons
gene
map
chromosom
posit
also
observ
patient
nezelof
syndrom
varieti
mutat
found
pnp
gene
patient
pnp
defici
although
ada
pnp
purin
salvag
pathway
enzym
pnp
defici
lead
sever
id
ada
defici
patient
consider
reduc
concentr
serum
urinari
uric
acid
number
cell
fall
progress
b
cell
tabl
like
prolifer
respons
mitogen
antigen
especi
pnp
defici
caus
intracellular
accumul
deoxygtp
guanosin
triphosph
inhibit
ribonucleotidereductas
tand
blymphocyt
prolifer
combin
b
defect
critic
pnpdefici
patient
profoundli
lymphopen
ada
defici
absolut
lymphocyt
count
usual
ig
level
product
specif
antibodi
normal
onset
may
earli
scid
also
delay
age
year
clinic
pattern
domin
recurr
bacteri
viral
fungal
infect
abnorm
suscept
opportunis
germ
twothird
vanc
liver
diseas
may
die
cryptosporidia
infect
progress
rapidli
follow
pretransplant
cytotox
condit
therapi
therefor
patient
endstag
liver
diseas
relat
defici
first
receiv
liver
graft
soon
livergraft
function
satisfactori
bmt
perform
nonmyeloabl
condit
protocol
fludarabin
melphalan
screen
defici
includ
children
sever
rri
dysgammaglobulinemia
normal
increas
igm
level
convent
allogen
hsct
hlamatch
match
unrel
donor
mud
cur
feasibl
perform
signific
infect
organ
damag
occur
approach
highrisk
patient
includ
nonmyeloabl
hsct
workabl
retrospect
analysi
european
patient
undergo
hsct
defici
eight
european
countri
donor
sc
sourc
includ
hlaident
sibl
mud
two
phenotyp
match
parent
stem
cell
sc
tcd
tcell
deplet
patient
die
infectionrel
complic
posit
result
patient
carrier
detect
use
make
prenat
diagnosi
patient
suffer
neurolog
alter
rang
spastic
symptom
alter
etc
mental
retard
onethird
aid
common
aiha
consequ
sever
infect
gener
vaccin
sever
chickenpox
lymphosarcoma
gvhd
caus
blood
transfus
first
decad
life
death
unless
bmt
success
howev
poor
neurodevelopment
progress
may
result
may
sinc
biochem
base
pnp
ada
defici
similar
hope
genet
treatment
also
effect
children
pid
defici
hla
molecul
express
occur
sever
form
pid
class
ii
case
known
ar
syndrom
heterogen
numer
complement
group
patient
divid
hla
class
ii
molecul
absent
tissu
extent
cell
patient
maintain
cultur
year
preserv
neg
phenotyp
defici
class
ii
gene
transactiv
ciita
codifi
chromosom
express
play
import
role
tcell
activ
absenc
make
class
ii
gene
express
imposs
function
share
anoth
protein
map
chromosom
bind
site
promot
region
gene
codifi
class
ii
chain
two
addit
class
iispecif
transcript
factor
rfxap
rfxank
act
class
ii
promot
region
essenti
also
nonreplac
extent
altern
rout
compens
absenc
furthermor
inactiv
defici
factor
specif
effect
gene
dictat
hla
class
ii
li
chain
hladm
indic
regul
system
may
involv
absenc
hla
class
ii
associ
lymphopenia
hla
class
express
normal
patient
test
lymphocyt
number
reduc
interestingli
twin
studi
despit
defici
antibodi
respons
class
iidepend
cell
henc
author
envisag
repres
hla
class
ii
residu
express
test
sensit
clinic
outlin
domin
earli
age
month
rang
week
month
sever
recurr
gastroenter
pulmonari
infect
sever
prolong
cours
associ
malabsorpt
failur
thrive
bacteri
viral
infect
bronchopneumonia
hepat
cholang
viral
meningoenceph
variou
autoimmun
manifest
common
complic
even
though
hla
class
ii
defici
clinic
less
sever
scid
result
uniformli
fatal
first
second
decad
life
evid
immun
defect
consist
complet
lack
reactiv
exogen
antigen
vivo
reflect
anergi
spt
well
complet
lack
hla
class
ii
express
absenc
cellular
antibodi
respons
antigen
stimul
instead
posit
mitogen
tabl
fig
laboratori
investig
show
normal
b
lymphocyt
number
children
may
agammaglobulinem
thymu
lymphoid
organ
remark
hypoplast
sever
lymphocyt
deplet
bcell
level
normal
syndrom
involv
defici
hla
antigen
confirm
import
hla
biolog
role
complex
system
tb
cooper
studi
suggest
type
defici
place
togeth
cultur
b
lymphocyt
patient
previous
transform
ebv
lymphocyt
correct
allow
hla
class
ii
molecul
express
led
identif
socal
complementari
group
specif
gene
map
chromosom
lead
earlier
prenat
diagnosi
longterm
surviv
seem
depend
primarili
hlaident
hlahaploident
bmt
perform
first
year
life
acquisit
chronic
viru
carriag
sequela
infect
child
recent
receiv
transplant
novel
protocol
count
increas
cellsml
direct
correct
genet
defect
base
transduct
cell
patient
lentivir
vector
encod
ciita
rfxank
rfxap
rfxank
vector
restor
class
ii
express
tcell
line
one
patient
rfxap
vector
correct
primari
cell
second
patient
studi
common
associ
hla
class
molecul
defici
alreadi
known
bare
lymphocyt
syndrom
led
identif
variou
patient
isol
defici
one
patient
defici
associ
class
ii
sever
defici
caus
mutat
accompani
sever
chronic
bacteri
rri
two
brother
ar
hla
class
defect
onset
rri
took
place
age
poor
express
nk
cell
sever
led
develop
bronchiectasi
immunolog
structur
character
defici
express
hla
class
molecul
diagnost
tabl
mutat
symptom
refer
id
therefor
integr
genet
heterogen
two
brother
parent
healthi
chain
defici
produc
modest
clinic
symptom
two
sever
also
immunolog
point
view
chain
defici
result
profound
decreas
caus
alter
thymic
activ
leav
unaffect
chain
due
sever
thymic
atrophi
thymocyt
fall
normal
level
limit
defici
due
herit
mutat
gene
prevent
synthesi
protein
report
case
hz
mutat
two
cousin
die
month
age
overwhelm
infect
thymu
shadow
clearli
visibl
chest
xray
thymu
becom
popul
develop
thymocyt
arrest
differenti
tcell
develop
girl
patient
surviv
bmt
rare
defici
transmit
ar
trait
caus
mutat
gene
nonsrc
famili
protein
tyrosin
kinas
ptc
import
tcell
signal
tabl
known
crucial
cell
activ
key
player
tcr
downmodul
z
degrad
essenti
role
chain
defici
due
g
e
gene
mutat
determin
lack
absenc
first
two
case
describ
one
brother
die
month
viral
pneumonia
clinic
histori
indic
scid
sever
aiha
asymptomat
age
year
although
molecular
defect
studi
brother
prove
spite
absenc
function
g
chain
express
level
complex
lymphocyt
normal
accord
author
chain
may
act
place
miss
one
howev
correl
scarciti
may
neg
interf
mechan
discrimin
self
nonself
g
chain
defici
could
modul
onset
deceas
brother
sever
autoimmun
diseas
aid
defici
found
child
mild
rri
symptom
otiti
media
express
complex
stimul
induc
normal
prolifer
respons
fact
despit
ongo
mutat
northern
blot
analysi
show
product
low
amount
transcrib
rna
correspond
small
quantiti
e
normal
chain
even
though
dimens
smaller
normal
one
z
chain
defici
found
two
brother
similar
defici
express
younger
brother
thymu
markedli
reduc
show
hassal
bodi
elder
brother
similar
chain
sever
babi
mennonit
origin
scid
nonfunct
cell
tabl
either
normal
increas
absenc
thymu
circul
suggest
select
process
arrest
transit
doubleposit
dp
monoposit
mp
cell
arrest
thymocyt
termin
rag
gene
express
upregul
tcr
express
fail
differenti
matur
mp
thymocyt
rescu
death
neglect
sustain
il
ra
express
defici
result
impair
transendotheli
migrat
rescu
transfect
crosstalk
signal
pathway
chemokin
receptor
requir
tcell
migrat
although
thymic
architectur
normal
presenc
hassal
bodi
seem
normal
cortex
migrat
medulla
near
absenc
cell
increas
ratio
domin
coexpress
nkcell
marker
b
cell
appear
normal
function
level
serum
ig
valu
normal
phenotyp
found
brother
rel
het
absenc
express
shown
correl
missens
mutat
ig
allel
gene
domain
man
sister
wherea
high
percentag
tcrab
cell
found
three
sibl
prolif
respons
vitro
phorbol
myrist
acet
pma
ionomycin
pkc
activ
protein
kinas
c
normal
unlik
pha
phytohemagglutinin
pwm
tetan
toxoid
etc
posit
oper
tcr
neg
react
directli
complex
confirm
defici
present
despit
defici
syk
member
famili
ensur
compensatori
role
infrathym
select
although
limit
efficaci
seven
month
bmt
child
clinic
well
immunolog
recov
studi
two
sibl
hz
stop
mutat
gene
suggest
nk
cell
express
still
unknown
inhibitori
receptor
miss
receptor
discuss
chap
capabl
downregul
nk
cell
cytotox
bind
surfac
ligand
express
cell
blast
function
analys
consist
concept
put
inhibitori
receptor
express
virtual
cell
wherea
present
rare
nk
cell
healthi
person
anoth
prospect
would
cell
actual
miss
still
unidentifi
trigger
receptor
involv
nk
cellmedi
kill
pha
blast
sinc
cell
deriv
patient
display
defect
express
either
tap
subunit
character
strong
reduct
matur
hla
class
molecul
cell
surfac
tap
defici
connect
hla
class
defici
discuss
chap
nfat
nuclear
factor
activ
cell
transcript
factor
form
power
transcript
activ
complex
link
specif
dnaregul
site
play
critic
role
synthesi
variou
tcell
il
due
defici
excess
migratori
mobil
nfat
although
normal
number
distribut
incap
activ
andor
secret
gene
il
il
ifng
girl
scid
present
infanc
sever
recurr
infect
failur
thrive
mrna
produc
il
ifng
due
poor
tcell
prolifer
although
normal
number
distribut
initi
transcript
rel
gene
regul
nfat
bind
site
proxim
region
sever
clinic
pictur
accompani
evid
hgg
nkcell
defici
found
scid
cvid
reticular
dysgenesi
syndrom
xlp
lad
defici
cf
chronic
fatigu
syndrom
particular
cid
scid
suggest
associ
nkand
tcell
defici
one
known
case
adolesc
isol
numer
function
defici
nk
cell
precursor
recurr
neutropenia
sever
recurr
ebv
cmv
herp
simplex
viru
hsv
infect
lifethreaten
chickenpox
anoth
child
diagnos
age
year
defici
suffer
sever
viral
bacteri
infect
although
antibodi
variou
virus
grow
list
human
genet
defect
impair
nkcell
function
recent
join
nemoid
occur
group
patient
antibodi
defici
combin
exquisit
suscept
infect
nontubercul
mycobacteria
infecti
suscept
common
disord
stress
import
role
nk
cell
host
defens
natur
histori
three
boy
nemo
mutat
outsid
exon
describ
includ
boy
famili
describ
nemoid
result
estim
incid
nemoid
live
male
birth
make
disord
significantli
less
common
cell
mark
clinic
improv
data
indic
thymu
differenti
requir
mainten
tcr
repertoir
complex
known
also
idiopath
lymphocytopenia
primari
tcell
defici
reveal
profound
persist
reduct
circul
cmi
defici
document
patient
suffer
infect
caus
opportunist
germ
cryptococcusinduc
mening
oral
candidosi
also
includ
ten
children
number
adolesc
follow
minimum
level
per
age
establish
cellsmm
month
year
total
lymphocyt
count
two
separ
occas
without
hivinfect
famili
report
involv
two
brother
age
count
recurr
respiratori
intestin
cutan
infect
failur
thrive
mother
show
low
ratio
entir
famili
show
normal
level
ig
subclass
hla
molecul
symptom
includ
mental
retard
pansinus
bronchiectasi
infect
caus
opportunist
germ
report
scientif
group
one
case
primari
defici
known
child
scid
without
genet
transmiss
defici
tcell
prolif
respons
mitogen
defect
il
r
express
defici
lymphocyt
b
cell
differenti
antibodysecret
cell
provid
help
normal
cell
index
patient
primari
defici
first
child
consanguin
kurdish
parent
present
age
month
rash
pyrexia
hepatosplenomegali
lymphadenopathi
pneumon
pancytopenia
dissemin
cmv
infect
laboratori
analysi
show
absolut
lymphopenia
low
cell
number
markedli
low
low
normal
b
cell
number
respond
well
anticmv
treatment
month
underw
mud
bmt
tcell
engraft
demonstr
week
bmt
despit
continu
anticmv
treatment
undifferenti
scid
human
defici
defici
ar
scid
due
defect
src
kinas
critic
gener
matur
thymocyt
adult
mice
import
tcr
signal
phosphoryl
itam
complex
protein
mutant
mice
lack
pronounc
thymic
atrophi
critic
reduct
dp
thymocyt
detect
mp
thymocyt
peripher
cell
prolifer
develop
given
defin
cell
subpopul
depend
meus
age
absolut
number
prolifer
dn
isp
immatur
singl
posit
thymocyt
prolifer
fetal
earli
postnat
life
day
birth
wherea
prolifer
significantli
decreas
beyond
age
thu
lck
may
differenti
role
prolifer
mainten
dn
isp
mpdp
thymocyt
popul
first
demonstr
human
scid
patient
abnorm
express
scid
infant
hospit
month
dehydr
failur
thrive
sepsi
immun
phenotyp
includ
hgg
select
lymphopenia
lack
express
cell
poor
cell
blastogen
respons
variou
mitogen
il
protein
express
minim
unusu
mrna
splice
pattern
lck
gene
level
normal
therefor
possibl
play
role
albeit
incomplet
develop
matur
cell
child
sinc
undergon
allogen
bmt
month
match
unrel
donor
mud
unfortun
boy
die
month
later
due
cmv
infect
gvhd
fd
goldman
per
comm
nov
whn
wingedhelixnud
encod
transcript
factor
crucial
matur
thymu
microenviron
nunu
mice
fail
develop
thymu
matur
cell
due
defect
whn
gene
encod
transcript
factor
necessari
termin
epitheli
cell
differenti
defect
whn
gene
could
lead
disrupt
earli
cell
develop
bm
cell
progenitor
associ
lack
pta
gene
express
failur
give
rise
matur
cell
adopt
euthym
host
wildtyp
hsc
rapidli
matur
function
cell
progenitor
marrow
euthym
thymectom
nunu
host
therefor
defect
bm
prethym
cell
develop
contribut
cell
defici
nunu
mice
two
sister
sever
scid
caus
mutat
whn
gene
associ
complet
alopecia
hlaident
bmt
one
two
girl
result
clear
reconstitut
cmv
reactiv
die
day
bmt
delet
gene
encod
result
loss
glutam
acid
tyrosin
first
fibronectin
type
iii
modul
extracellular
domain
identifi
region
import
structur
integr
lack
surfac
express
almost
certainli
respons
id
girl
second
child
present
month
age
sever
cid
show
similar
tcell
defect
despit
normal
blymphocyt
number
serum
ig
level
decreas
age
introduct
function
minigen
suffici
overcom
main
scidassoci
defect
repres
potenti
rout
gene
therapi
human
scid
two
male
infant
born
consanguin
parent
scid
despit
phenotyp
normal
blood
lymphocyt
cell
unabl
produc
il
ifng
il
tnfa
anoth
child
scid
defect
transcript
il
gene
encod
il
il
dna
bind
activ
protein
oct
creb
nfk
b
normal
bind
nfat
il
promot
respons
element
abil
nuclear
factor
child
lymphocyt
bind
respons
element
present
il
regulatori
region
bare
detect
tcell
stimul
result
indic
nfat
abnorm
may
underli
multipl
il
defici
boy
nezelof
syndrom
also
known
cellular
id
ig
combin
predomin
tcell
defect
scid
variant
clinic
less
sever
compar
previou
one
character
form
ad
concentr
ige
may
also
extrem
elev
tabl
normal
increas
serum
level
ig
class
cmi
studi
emphas
matur
tcell
reduct
absenc
variou
express
immatur
cell
cutan
anergi
spt
reduc
absent
vitro
lymphocyt
respons
mitogen
infanc
patient
present
recurr
chronic
pulmonari
infect
pondostatur
retard
oral
andor
cutan
candidosi
chronic
diarrhea
recurr
cutan
urinari
tract
infect
gramneg
bacteri
sepsi
particularli
sever
form
chickenpox
differenti
diagnosi
must
includ
pediatr
aid
also
mark
proportion
increas
ig
lack
antibodi
tcell
function
inherit
ar
modal
defici
observ
children
two
brother
mutat
fa
gene
one
hz
het
well
unrel
children
mutat
often
aris
result
mutat
gene
encod
lymphocyt
apoptosi
receptor
novel
mutat
identifi
intracellular
apoptosi
signal
domain
fa
member
famili
sever
member
monitor
year
thu
defici
inherit
autosom
domin
fashion
high
degre
variabl
clinic
express
also
ar
fashion
clinic
pictur
domin
impos
hepatosplenomegali
earli
onset
even
neonat
accompani
tcell
hyperprolifer
chronic
persist
lymphadenopathi
failur
thrive
extens
lymphocyt
infiltr
lymph
node
spleen
liver
observ
cell
reach
dn
equal
cellsml
compar
control
omenn
syndrom
also
bloodstream
possibl
oligoclon
cellular
dn
cell
express
ab
tcr
immun
dysregul
associ
g
hgg
hypergammaglobulinemia
autoantibodi
aid
especi
hematolog
type
aiha
sever
recurr
thrombocytopenia
autoimmun
featur
discuss
chap
overlap
mechan
could
belong
etiopathogenesi
xlp
omenn
syndrom
preval
approxim
live
birth
transmit
recess
hereditari
trait
link
chromosom
x
local
pericentrometr
posit
short
limb
chromosom
x
therefor
possibl
identifi
femal
carrier
provid
prenat
diagnosi
gene
codifi
defect
protein
wasp
isol
mutat
distribut
among
exon
entir
gene
uniqu
familiar
two
larg
delet
one
embrac
exon
one
intron
fig
six
novel
mutat
identifi
involv
nonsens
mutat
small
delet
result
predict
truncat
wasp
synthesi
new
recurr
mutat
due
cpg
island
found
hz
girl
show
microthrombocytopenia
infect
degre
hemizyg
father
brother
amount
protein
platelet
mononucl
white
cell
involv
ensur
lymphocyt
function
polyval
also
explain
microvilli
platelet
defect
absent
wasp
sever
relat
protein
wasp
famili
involv
organ
actin
cytoskeleton
carri
vital
function
cell
rearrang
actin
cytoskeleton
characterist
peculiar
wasp
meet
point
mark
pathway
illustr
fig
wasp
function
absent
case
ten
attenu
xlt
normal
subject
found
cytomolecular
biolog
proven
wasp
found
blood
cell
bind
small
gtpase
gtp
gdp
play
critic
role
assembl
actin
filament
tcell
polar
encount
blymphocyt
apc
wasp
activ
regul
sever
protein
act
concert
control
wasp
configur
waspinteract
protein
phosphoryl
releas
wasp
grip
allow
wasp
activ
rhofamili
gtpase
experiment
data
also
indic
wasp
actin
might
plasm
nucleu
variou
cell
platelet
b
lymphocyt
monocyt
xlt
gene
locat
locu
could
therefor
variant
main
immunolog
anomali
summar
tabl
children
significantli
elev
level
il
ige
tabl
decreas
level
pathogenet
mechan
unifi
symptom
triad
clear
glycosyl
defect
prove
primarili
concern
sialid
therefor
result
instabl
membran
platelet
neutrophil
lymphocyt
express
glycoprotein
sialopherin
local
chromosom
make
improb
candid
even
though
inde
bind
agent
could
therefor
play
role
tcell
matur
differenti
activ
therebi
acquir
mark
capac
independ
howev
tcrmediat
signal
defect
characterist
addit
reduc
express
explain
immun
hematolog
defect
lymph
node
shortag
lymphat
follicl
thymusdepend
independ
area
deplet
moder
age
year
fig
greater
extent
year
fig
predomin
immunolog
outlin
constitut
elev
iga
ige
level
low
igm
igg
level
well
absenc
respons
polysaccharid
antigen
children
serum
lack
isohemagglutinin
unwean
babi
strike
find
ratio
compar
normal
children
age
tabl
usual
start
month
rang
hemorrhag
manifest
petechia
prolong
bleed
umbil
scar
circumcis
site
observ
newborn
babi
clinic
triad
character
cutan
lesion
practic
indistinguish
rather
sever
ad
congenit
thrombocytopenia
mark
suscept
rri
fig
gastroenter
symptom
hematemesi
melena
chronic
diarrhea
complic
may
includ
neutropenia
arthriti
skin
vascul
cerebr
vascul
inflammatori
bowel
diseas
renal
diseas
reduc
thrombopoiesi
level
microthrombocyt
acceler
turnov
boy
must
allow
suspect
diagnosi
recent
proven
classic
present
common
children
age
month
age
month
compar
unlik
platelet
count
howev
unselect
children
persist
thrombocytopenia
posit
fh
small
platelet
defect
associ
andor
b
line
classic
triad
thrombocytopenia
diagnosi
primari
immunodefici
infect
appear
first
month
life
often
mark
otiti
media
pneumonia
mening
sepsi
caus
virus
cmv
herpesviru
bacteria
pneumococci
capsular
polysaccharid
follow
common
infect
caus
opportunist
germ
pneumocysti
carinii
mycet
candida
albican
differenti
diagnosi
also
includ
rare
ar
syndrom
similar
also
report
femal
patient
character
ad
rri
thrombocytopenia
microthrombocyt
care
children
one
must
monitor
platelet
count
immunolog
structur
ig
lymphocyt
subpopul
count
potenti
onset
autoimmun
tumor
aiha
may
found
children
prophylact
treatment
infect
done
ivig
mgkg
everi
week
sulfamethoxazol
mg
day
diagnosi
splenectomi
may
decreas
bleed
tendenc
earli
relaps
thrombocytopenia
splenectomi
predict
poor
prognosi
averag
death
occur
around
age
untreat
children
occur
surviv
also
death
caus
massiv
hemorrhag
tumor
sever
infect
second
largest
group
patient
id
given
bmt
sinc
children
age
year
fourteen
patient
underw
phenoident
haploident
hsct
four
die
hsct
could
undertaken
boy
receiv
mud
hsct
transplant
year
surviv
rate
similar
receiv
hlaident
sibl
transplant
success
rate
decreas
dramat
age
wasassoci
tcell
signal
defect
improv
upon
retrovir
transduc
hsct
recent
correct
tcell
defect
propos
potenti
correct
tcell
defect
recent
demonstr
transduct
oncoretrovir
vector
encod
wasp
result
correct
defici
prolif
respons
tcr
stimul
characterist
ata
complex
ar
inherit
syndrom
associ
neurolog
immunolog
endocrinolog
hepat
cutan
abnorm
character
progress
cerebellar
ataxia
oculocutan
telangiectasia
increas
suscept
rri
incid
estim
live
birth
itali
frequenc
gener
popul
increas
het
character
genet
heterogen
reflect
divis
four
main
group
complement
one
must
add
nijmegen
atfresno
variant
perhap
caus
welldefin
id
syndrom
gene
also
local
long
arm
chromosom
gene
call
atm
mutat
mutat
defect
splice
patient
ata
permit
het
identif
dna
clone
complementari
atm
show
consider
affin
factor
respons
signal
involv
regul
cell
cycl
codifi
protein
similar
pi
involv
mitot
signal
transduct
meiotic
recombin
cell
cycl
control
result
could
recombin
defect
interfer
b
lymphocyt
gene
rearrang
involv
tcr
isotyp
switch
consequ
damag
dna
triplic
therefor
account
ig
defici
cell
patient
progress
rapidli
g
phase
receiv
ioniz
radiat
phase
continu
irradi
g
phase
delay
evolv
apoptosi
hypothesi
receiv
credit
observ
gene
express
increas
human
cell
expos
radiat
gene
part
normal
cell
cycl
phase
provid
time
dna
physiolog
repair
exposur
radiat
may
also
cosmic
thymic
tissu
either
absent
degener
fetal
appear
fig
follicl
also
b
cell
visibl
age
fig
complet
cellular
deplet
fig
immun
defici
humor
cellular
cutan
anergi
depress
prolif
respons
karyogram
show
lymphocyt
common
ruptur
point
chromosom
level
invers
transloc
involv
precis
tcr
ig
gene
chromosom
transloc
involv
gene
encod
tcr
chromosom
ig
h
chain
chromosom
breakpoint
occur
loci
encod
ig
tcr
antigen
region
area
typic
codif
molecul
immunolog
import
chap
import
role
play
gene
belong
ig
gene
superfamili
igsf
tabl
possibl
progress
id
ata
like
appar
unlink
manifest
least
part
link
accumul
clonal
anomali
affect
tcr
igsf
suggest
intervent
illegitim
recombin
damag
cell
tcell
immunolog
defici
complet
lymphopenia
decreas
ratio
due
drop
cytotox
rise
immatur
form
tcrgd
anoth
consequ
isotyp
defici
patient
present
sigad
also
affect
igg
igg
defici
igm
becom
monoclon
serum
igg
defici
fig
degre
deplet
lymphocyt
extens
thymusdepend
thymusindepend
area
chromosom
cell
chromosom
aberr
induc
xray
suppress
rare
ar
nijmegen
breakag
syndrom
call
initi
seen
two
brother
secondcousin
parent
live
citi
moment
observ
approxim
patient
variou
characterist
ata
without
ataxia
telangiectasia
high
concentr
afp
clinic
characterist
singular
short
statur
microcephali
prenat
onset
birdlik
profil
promin
midfac
long
nose
lowset
ear
cutan
depigment
spot
almost
normal
intellig
also
rri
bronchiectasi
humor
cellular
id
includ
reduct
antibodi
lymphoprolif
respons
period
observ
id
found
profound
highli
variabl
tendenc
progress
time
children
high
procliv
express
rearrang
chromosom
ata
dg
usual
sporad
known
case
posit
fh
caus
defect
develop
rd
th
branchial
pouch
take
place
th
week
gestat
consequ
thymic
hypoplasia
aplasia
parathyroid
hypoplasia
th
th
pouch
branchial
arch
also
affect
caus
found
neural
crest
cell
incapac
migrat
interact
appropri
endotherm
cell
brachial
pouch
arch
delet
often
microdelet
pericentrometr
region
chromosom
describ
case
microdelet
record
children
age
month
development
delay
mild
hypotonia
well
languag
speech
delay
anoth
children
deficit
area
attent
stori
visuospati
memori
arithmet
perform
rel
area
achiev
psychosoci
function
mental
retard
children
thu
indic
need
earli
intervent
begin
infanc
overlap
alter
present
syndrom
complex
known
catch
turn
includ
charg
associ
case
dg
deriv
microdelet
chromosom
fetalalcohol
syndrom
retino
embryopathi
matern
diabet
variabl
phenotyp
reliabl
refer
microdelet
greater
complex
associ
phenotyp
anoth
differ
depend
variabl
spectrum
tcell
abnorm
individu
dg
might
normal
tcell
number
function
low
tcell
number
fairli
normal
tcell
prolif
function
cell
purkinj
cell
pc
degener
granular
cell
number
basket
cell
call
form
axon
bunch
fibril
distribut
form
nest
nucleu
pc
settl
almost
normal
prove
pc
probabl
normal
birth
degener
later
typic
clinic
manifest
ataxia
telangiectasia
auricular
lobe
sclera
rri
elev
incid
neoplasia
review
patient
percentag
symptom
follow
progress
ataxia
typic
cerebellar
becom
evid
children
start
walk
littl
later
affect
intent
movement
becom
complic
dysarthria
involuntari
choreic
movement
caus
major
unabl
walk
age
later
stage
possibl
observ
nystagmu
strabismu
oculomotor
apraxia
reduct
absenc
reflex
dyslalia
increasingli
amplifi
patient
also
mental
retard
telangiectasia
develop
age
bulbar
conjunctiva
fig
flexor
surfac
limb
area
expos
sun
ray
height
weight
percentil
appear
proger
sever
rri
common
encourag
antibodi
defici
pathogen
involv
bacteri
viral
often
result
lung
bronchiectasi
start
onset
neurolog
manifest
associ
neoplasia
usual
lymphoreticular
less
common
adenocarcinoma
eightfold
increas
trend
kind
tumor
cultur
fibroblast
patient
three
time
sensit
compar
control
ioniz
radiat
radiomimet
chemic
substanc
uv
ray
unlik
observ
cell
subject
affect
xeroderma
pigmentosum
addit
persist
elev
serum
afp
level
observ
patient
interest
vitro
studi
report
introduc
normal
human
welldefin
id
syndrom
fig
conjunctiv
telangiectasia
girl
ata
second
group
refer
partial
dg
dgsp
transient
form
dgst
mild
symptom
design
complet
digeorg
syndrom
dgsc
reserv
third
group
infant
absenc
thymic
function
addit
defect
rd
th
pharyng
pouch
patient
dg
although
high
tcell
number
respond
mitogen
patient
profound
id
associ
clinic
find
dgst
includ
case
spontan
quantit
qualit
lymphocyt
recoveri
thymu
also
ectop
dgsc
zone
deplet
markedli
reduc
number
function
spt
anergi
b
cell
appear
unaffect
increas
dgsp
common
type
tcell
number
function
instead
usual
normal
cell
nk
phenotyp
may
moder
reduc
prolif
respons
mitogen
patholog
reduc
respons
polysaccharid
antigen
may
absent
neonat
age
malform
structur
form
first
week
embryogenesi
present
suggest
pathognomon
pictur
tabl
diagnosi
usual
suspect
within
first
day
birth
due
presenc
hypocalcem
tetani
caus
hypoparathyroid
cardiac
malform
facial
dysmorph
also
character
small
mouth
thin
lip
describ
fishlik
fig
two
rare
cardiopathi
indic
tabl
depend
neural
crest
nonintegr
mention
account
alter
alon
other
observ
affect
right
heart
fallot
tetralog
pulmonari
athresia
interventricular
septum
defect
pulmonari
infundibular
stenosi
babi
surviv
neonat
period
manifest
first
month
increas
suscept
infect
particularli
respiratori
digest
tract
viral
andor
fungal
also
caus
pneumocysti
carinii
fatal
dgsc
find
includ
gastroesophag
reflux
speech
delay
laryngomalacia
absent
kidney
conduct
sensorineur
deaf
cranial
nerv
palsi
hypothyroid
treatment
high
dose
vitamin
diet
enrich
ca
glucon
need
immedi
also
ensur
calcemia
remain
lower
limit
normal
valu
avoid
snc
renal
damag
subsequ
possibl
correct
cardiac
malform
evalu
id
may
sever
regress
spontan
reconstitut
cmi
function
compens
hyperplasia
residu
parathyroid
tissu
make
possibl
discontinu
ca
vitamin
treatment
dg
natur
histori
howev
complic
mental
retard
difficulti
encount
correct
cardiac
malform
control
hypoparathyroid
variabl
id
sever
difficult
evalu
claim
benefit
bmt
two
cohort
transplant
infant
survivor
recent
infant
underw
postnat
transplant
cultur
unrel
thymic
tissu
immunosuppress
posit
result
syndrom
character
delet
chromosom
frequent
known
chromosom
microdelet
syndrom
incid
livebirth
patient
show
chapter
primari
immunodefici
clinic
outlin
unlik
gvhd
fig
suggest
possibl
connect
fa
defici
apoptosi
syndrom
gene
found
alter
two
famili
thu
indic
xlp
must
consid
one
male
patient
cvid
encount
famili
must
analyz
male
patient
cvid
recent
critic
revisit
experi
natur
allow
identif
link
id
allergi
rare
hige
associ
bacteri
rri
chronic
ad
coars
facial
featur
elev
ige
level
tabl
iuml
linkag
region
chromosom
demonstr
sever
affect
famili
howev
neither
fundament
host
defect
defect
gene
yet
identifi
fh
frequent
posit
atop
diseas
time
hige
combin
unusu
predisposit
staphylococcu
aureu
infect
buckley
studi
present
case
sex
indic
autosom
domin
transmiss
incomplet
penetr
onset
occur
pediatr
age
case
clinic
present
unusu
complaint
first
month
life
toward
month
sever
form
chronic
ad
appear
bodi
associ
allerg
manifest
includ
asthma
case
skin
biopsi
specimen
reveal
spongiosi
perivascular
dermat
andor
follicul
predomin
eosinophil
excess
predisposit
cutan
respiratori
tract
infect
deep
superfici
abscess
otiti
pneumonia
sepsi
fig
also
encourag
neutrophil
chemotact
defici
caus
defect
cellular
function
tabl
present
pronounc
becom
characterist
unlik
ad
secondari
subcutan
abscess
describ
cold
cover
warm
redden
skin
pathognomon
hige
essenti
diagnosi
abscess
fill
pu
alway
grow
staphylococcu
aureu
case
mucocutan
candidosi
chronic
herpet
kerat
associ
infect
appear
within
first
month
face
show
coars
dysmorph
featur
midlin
facial
defect
promin
nose
high
arch
palat
disproportion
cheekbon
mandibl
pondostatur
growth
notabl
retard
pneumatocel
fig
osteoporosi
caus
reduc
bone
densiti
tendenc
fractur
complet
pictur
six
consanguin
famili
report
ar
form
hige
includ
cardiac
abnorm
tcell
deficit
cleft
palat
facial
anomali
hypocalcaemia
least
gene
map
delet
region
recent
patient
syndrom
without
delet
mutat
found
tbox
major
genet
determin
syndrom
xlp
caus
defect
gene
tabl
bind
cytoplasm
domain
slam
signal
lymphocyt
activ
molecul
may
regul
signal
transmit
receptor
nk
cell
respect
xlp
report
male
famili
male
inherit
xlink
model
set
male
age
ebv
infect
becam
manifest
polymorph
pattern
often
unusu
sever
fatal
infect
mononucleosi
caus
immun
system
incapac
respond
ebv
evolv
hgg
iga
igg
defici
higm
medullar
aplasia
andor
burkitt
type
lymphoma
diseas
report
femal
subject
xlp
polymorph
could
explain
fact
ebv
receptor
express
differenti
b
lymphocyt
start
preced
isotyp
convers
stage
recent
verifi
ebv
infect
male
alreadi
suffer
dysor
panhgg
incap
regul
express
ig
andor
contain
b
lymphoprolifer
even
ebv
infect
immun
system
unabl
provid
adequ
respons
therefor
releas
cytotox
alloreact
cell
il
caus
extens
damag
entir
parenchyma
exemplifi
fulmin
hepat
cellular
infiltr
tissular
necrosi
lymphoid
tissu
alter
structur
also
affect
necrosi
high
incid
mostli
nonloc
lymphoma
thymu
also
affect
thymocyt
rarif
welldefin
id
syndrom
fig
bone
marrow
biopsi
specimen
boy
numer
histiocyt
erythrophagocytosi
affect
children
age
month
year
arhig
present
classic
immunolog
find
includ
rri
eczema
elev
serum
ige
hypereosinophilia
sever
recurr
fungal
viral
infect
notabl
patient
arhig
skelet
dental
abnorm
develop
pneumatocel
seen
autosom
dominanthig
among
immunolog
characterist
tabl
cutan
anergi
sever
antigen
candida
tetan
toxoid
characterist
associ
anomali
prolif
respons
cell
antigen
mitogen
contrast
integr
function
test
vitro
subpopul
appear
normal
howev
lymphocyt
prolifer
monoclon
antibodi
impair
note
defici
associ
patholog
preval
fundament
impact
ige
hyperproduct
hige
studi
confirm
ifng
defici
compar
control
also
due
impair
respons
il
other
howev
compar
ad
normal
level
produc
il
characterist
consid
ifngil
correl
ad
hige
specif
tcell
anomali
note
hyperig
explain
pediatr
abnorm
suscept
infect
high
ige
level
also
seen
children
ad
howev
unusu
predisposit
abscess
format
one
typic
characterist
sige
direct
microbi
antigen
antistaphylococc
sige
rise
compar
normal
level
anoth
constant
find
increas
case
eosinophil
concentr
make
leukocyt
reach
express
duo
stimul
isotyp
bcell
switch
igew
studi
children
affect
sever
ad
chronic
fainduc
diarrhea
asthma
allergen
respons
cm
der
p
case
hige
caus
fa
atop
manifest
clearli
improv
follow
exclus
diet
reduc
frequenc
infect
partial
correct
immun
defect
reveal
fa
induc
sever
immunolog
anomali
diagnosi
made
basi
data
tabl
differenti
diagnosi
ad
schemat
tabl
treatment
cromolyn
extrem
effect
antistaphylococc
antibiot
treatment
necessari
antifung
therapi
provid
good
result
griscelli
diseas
map
chromosom
ar
syndrom
caus
mutat
mlph
gene
lead
similar
pigmentari
dilut
diseas
also
character
partial
oculocutan
albin
predisposit
pyogen
infect
patient
abnorm
regul
immun
system
result
syndrom
macrophag
hyperactiv
known
hemophagocyt
lymophohistiocytosi
mutat
gtpbind
protein
appear
involv
uncontrol
lymphocyt
macrophag
activ
syndrom
lead
death
absenc
bmt
occur
syndrom
mutat
found
gene
associ
primarili
neurolog
impair
two
ident
twin
boy
age
month
report
persist
fever
mouth
ulcer
hepatosplenomegali
pancytopenia
failur
thrive
infant
infant
silverygray
hair
pigment
clump
hair
shaft
skin
biopsi
show
accumul
melanocyt
melanosom
parent
first
cousin
sibl
similar
manifest
alreadi
die
twin
genet
studi
reveal
delet
gene
del
aagcc
exon
child
hemophagocyt
syndrom
id
secondari
neurolog
disord
typic
melanosom
accumul
found
skin
melanocyt
pigment
clump
observ
hair
shaft
two
heterozyg
mutant
allel
gene
ct
transit
lead
gc
transvers
exon
splice
donor
site
found
find
gray
strand
hair
gray
eyebrow
eyelid
childhood
alert
pediatrician
consid
griscelli
syndrom
sinc
earli
diagnosi
lifeand
healthsav
phagocyt
system
biochem
basi
cgd
analyz
within
framework
innat
immun
chronic
granulomat
diseas
cgd
overal
preval
although
could
underr
tabl
consid
subject
may
mild
clinic
phenotyp
escap
diagnosi
us
registri
birth
rate
found
preval
live
birth
period
youngest
patient
day
old
children
cgd
mean
age
onset
infect
month
median
delay
diagnosi
year
otherwis
clinic
featur
rare
ar
diseas
includ
oculocutan
albin
suscept
especi
aureu
bhemolyt
streptococcu
approxim
patient
develop
acceler
phase
diseas
deposit
lymphohistiocyt
liver
spleen
lymph
node
bm
result
hepatosplenomegali
lymphadenopathi
bm
infiltr
hemophagocytosi
pancytopenia
well
fever
jaundic
prolong
bleed
easi
bruisabl
neurolog
chang
nystagmu
neuropathi
mild
mental
retard
partial
ocular
cutan
albin
cellular
hallmark
diseas
includ
larg
lysosom
granul
leukocyt
giant
melanosom
melanocyt
affect
cell
bodi
neural
schwann
cell
renal
tubular
cell
gastric
mucosa
pneumocyt
hepatocyt
langerhan
cell
skin
adren
cell
fundament
defect
disord
found
caus
mutat
gene
map
chromosom
encod
cytosol
protein
chromosom
name
lysosomaltraffick
lyst
regul
encod
protein
whose
function
remain
unknown
bmt
resolut
children
normal
protein
express
form
total
absenc
oxidas
due
incorrect
bind
arcgd
caus
mutat
gene
encod
remain
oxidas
kd
phox
phox
phagocyt
oxidas
phox
kd
cyba
phox
kd
arcgd
form
case
identifi
use
immunoblot
techniqu
depend
whether
affect
phox
phox
phox
greater
preval
american
studi
patient
xcgd
appear
seriou
clinic
phenotyp
patient
arcgd
base
fact
diagnos
significantli
earlier
mean
year
age
vs
year
age
respect
significantli
higher
preval
infect
higher
mortal
vs
mutat
structur
molecul
tabl
lead
cgd
mutat
see
lad
predomin
g
protein
neutrophil
lead
defect
product
well
chemotaxi
activ
nadph
oxidas
requir
complex
rearrang
protein
median
age
onset
month
median
age
diagnosi
year
defici
appear
two
form
hchain
defici
divid
four
subtyp
tabl
also
identifi
basi
nbt
result
depend
whether
absent
common
form
reduc
present
inact
subtyp
divid
two
variant
one
nbt
slightli
posit
cell
patient
patient
precis
four
subtyp
caus
mutat
four
phox
region
mani
depend
cybb
gene
mutat
caus
form
mutat
depend
nadphoxidas
activ
eight
other
lead
phagocyt
defici
subunit
part
mediat
noncoval
bind
srchomolog
domain
domain
prolinerich
motif
cgd
hereditari
diseas
tabl
character
sever
recurr
pyogen
infect
mark
suscept
caus
phagocyt
incapac
kill
particular
catalaseposit
bacteria
genet
defect
nadphoxidas
enzymat
system
situat
wall
phagocyt
vacuol
cgd
phagocytosi
occur
normal
nadphoxidas
unabl
markedli
produc
anion
superoxid
h
free
radic
therebi
permit
surviv
microorgan
within
cell
protect
antibodi
antibiot
anoth
consequ
lack
radic
develop
countless
inflammatori
episod
result
typic
granuloma
nitroblu
tetrazolium
nbt
reduct
test
base
chemic
characterist
fact
phagocyt
without
unabl
reduc
yellow
nbt
product
activ
pha
aspecif
stimul
phagocyt
specif
corpuscl
particl
preopson
yeast
fig
result
children
molecular
level
gene
codifi
two
subunit
flavocytochrom
phox
phox
clone
respect
cytochrom
h
b
l
chain
situat
phagosom
vacuol
membran
also
cytosol
factor
phox
phox
phox
deriv
nadphoxidas
activ
protein
place
insid
cytoplasm
belong
innat
immun
therefor
possibl
identifi
molecular
lesion
cgd
origin
except
clinic
pattern
sever
form
variabl
two
form
onset
occur
within
year
life
case
other
within
year
although
appear
also
age
purul
recurr
infect
granulomat
evolut
predominantli
affect
epitheli
surfac
normal
colon
bacteria
cutan
subcutan
mucou
membran
respiratori
tract
intestin
cutan
mucos
infect
lymphaden
lead
suppur
fistul
fig
pneumonia
lung
abscess
fig
frequent
character
persist
fever
diarrhea
tabl
pneumonia
preval
infect
patient
mostli
aspergillu
follow
suppur
aden
subcutan
abscess
liver
abscess
mostli
staphylococcu
osteomyel
mostli
serratia
sepsi
salmonella
longterm
trial
pneumon
preval
infect
follow
lymphaden
aphthou
stomat
liver
abscess
chronic
lung
diseas
rate
consist
first
second
number
relat
european
studi
us
data
regard
ar
cgd
parenthes
data
x
xlink
ar
autosom
recess
ad
autosom
domin
inherit
nd
done
superscript
symbol
indic
level
immunoreact
protein
undetect
diminish
normal
protein
level
granuloma
entir
lung
parenchyma
form
mononucl
fig
giant
cell
fig
chronolog
infect
onset
summar
tabl
lymphaden
earliest
osteomyel
usual
worri
complic
lymphaden
lung
infect
enter
infect
hepat
abscess
frequent
infect
cohort
children
staphylococc
liver
abscess
almost
pathognomon
cgd
infect
develop
area
drain
lymphat
tend
diffus
via
lymphohematogen
rout
thu
caus
arthriti
osteomyel
abscess
format
especi
affect
bone
sever
manifest
hepat
common
upsurg
hepatosplenomegali
lung
infect
almost
rule
initi
segment
parallel
tend
gradual
spread
entir
lobe
histolog
examin
show
widespread
gastric
outlet
obstruct
urinari
obstruct
extens
bone
destruct
involv
variou
segment
exampl
vertebra
metacarpu
metatarsu
caus
widespread
damag
difficult
treat
also
irrevers
aspergillu
pulmonari
bone
fig
encephal
infect
constitut
sever
therapeut
problem
threaten
event
mortal
rate
specif
treatment
prognosi
good
far
recoveri
concern
treatment
includ
prophylaxi
trimethoprimsulfamethoxazol
tmpsmx
mgday
given
two
divid
dose
ifng
mgm
subcutan
thrice
weekli
patient
cgd
regardless
genotyp
itraconazol
therapi
mgkgday
excel
toler
case
effect
children
surviv
age
beyond
achiev
patient
cgd
xl
cgd
ar
prognosi
uncertain
observ
possibl
definit
resolut
bmt
famili
donor
xcgd
xcgdident
bmt
success
children
see
tabl
includ
boy
xcgd
underw
success
hlaident
peripher
blood
sc
transplant
invas
pulmonari
aspergillosi
osteomyel
unrespons
antifung
treatment
lad
due
mutat
gene
chromosom
posit
encod
tabl
divid
five
type
lad
type
lad
type
v
three
subunit
complex
involv
pid
lad
type
syndrom
ar
link
lack
b
equal
tabl
surfac
express
leukocyt
popul
caus
differ
mutat
encod
gene
often
sever
infanc
children
defici
integrin
defect
phagocyt
action
suffer
sever
infect
neonat
period
due
absent
activ
impair
neutrophil
abil
exit
circul
travel
site
infect
contrari
leukocyt
movement
prevent
indic
normal
involv
tabl
clinic
basi
defin
diseas
describ
case
date
back
studi
soothil
school
two
form
lad
type
defici
full
blown
detect
clinic
symptom
tabl
domin
sever
recurr
infect
neg
prognosi
first
year
life
unless
correct
allogen
bmt
resolut
treatment
instead
partial
defici
residu
express
clinic
outlin
less
sever
patient
appropri
treatment
live
adult
age
lad
type
ii
ar
level
normal
level
molecular
base
repres
slex
ligand
defect
common
e
p
mediat
neutrophil
roll
absenc
gdpfucos
transport
slex
made
lad
type
result
mutat
transport
take
fucos
golgi
apparatu
posttransl
fucosyl
newli
synthes
protein
ligand
without
leukocyt
make
initi
attach
vascular
endothelium
lad
describ
two
children
age
mental
retard
differ
famili
parent
blood
rel
lower
mortal
rate
mice
defici
selectin
show
ladlik
syndrom
provid
use
model
studi
syndrom
lad
type
iii
show
defect
tether
adhes
bleed
diathesi
new
syndrom
vitro
leukocyt
show
normal
roll
along
endotheli
cell
cultur
defect
tether
tight
adhes
thu
defect
capabl
vascular
integrin
circul
leukocyt
rearrang
endotheli
ligand
adhes
contact
rapidli
arrest
target
vascular
endothelium
respons
endothelialdisplay
chemoattract
howev
express
level
major
integrin
lymphocyt
neutrophil
larg
conserv
patient
cell
rule
ladi
syndrom
patient
leukocyt
show
ladii
like
fucosyl
defect
sinc
express
normal
level
fucosyl
marker
compris
slex
carbohydr
selectin
ligand
defect
leukocyt
platelet
function
biochem
molecularli
distinct
adhes
disord
previous
describ
suggest
mutat
earli
myeloid
pathway
defect
associ
regul
gtpase
activ
protein
demonstr
intact
express
activ
phorbol
ester
thu
rule
lad
defect
gtp
load
lad
type
iv
manifest
defect
express
tether
girl
develop
pseudomona
omphal
week
age
recurr
ear
urinari
tract
infect
clinic
evid
impair
pu
format
reminisc
lad
syndrom
neutrophil
function
normal
express
normal
level
slex
howev
patient
show
absenc
endothelium
although
eselectin
mrna
present
contrast
patient
lad
mild
chronic
neutropenia
appropri
leukocyt
increas
respons
infect
gmcsf
bm
biopsi
perform
period
health
show
normal
cellular
age
fh
remark
previou
sibl
die
week
gestat
staphylococc
infect
fetu
amniot
fluid
phagocyt
defici
placenta
also
two
halfsist
complet
well
fh
neg
recurr
infect
either
parent
distant
rel
lad
type
v
caus
defici
boy
born
unrel
parent
delay
uc
separ
perirect
abscess
poor
wound
heal
absent
pu
site
infect
set
neutrophilia
suggest
neutrophil
defect
neutrophil
exhibit
decreas
chemotaxi
polar
azurophil
granul
secret
well
significantli
reduc
stimul
superoxid
product
normal
express
upregul
constitut
rac
neutrophil
boy
multipl
recurr
lifethreaten
infect
character
leukocytosi
notabl
absenc
pu
inflam
tissu
report
presenc
densiti
normal
express
also
normal
bmt
cur
boy
share
phenotyp
close
mimick
mous
mutant
defici
rho
gtpase
diseas
shown
attribut
ad
mutat
rho
gtpase
amino
acid
need
proper
interact
intracellular
protein
compris
critic
import
g
protein
rac
neutrophil
member
famili
appear
control
distinct
function
actin
cytoskeleton
chemotaxi
degranul
nadph
oxidas
superoxid
product
function
male
child
mother
first
pregnanc
born
term
parent
arab
ethnic
origin
first
cousin
sever
genet
disord
associ
function
defect
multipl
leukocyt
integrin
reflect
recurr
infect
profound
leukocytosi
bleed
diathesi
platelet
transfus
antibiot
cours
reduc
symptom
remain
signific
clinic
problem
age
year
die
dissemin
fungal
infect
mismatch
bmt
younger
brother
present
clinic
hematolog
phenotyp
birth
die
age
week
sepsi
convert
gener
nadph
h
ion
nadp
nadph
oxidas
catalyz
monoval
reduct
subsequ
convers
h
superoxid
dismutas
form
partial
defici
known
caus
hemolyt
anemia
favism
enzym
residu
activ
permit
normal
bactericid
activ
variant
classifi
level
residu
enzym
activ
propens
hemolysi
group
five
class
class
sever
defici
chronic
hemolyt
anemia
class
ii
sever
defici
occasion
hemolyt
anemia
residu
activ
class
iii
moder
defici
residu
activ
class
iv
normal
activ
class
v
increas
activ
trial
subject
origin
differ
part
itali
greater
molecular
heterogen
describ
other
observ
especi
sardinia
complet
defici
sexual
transmit
whose
gene
local
chromosom
x
posit
character
sever
mutat
variant
consequ
defici
bactericid
activ
neutrophil
unabl
kill
aureu
e
coli
serratia
therefor
increas
suscept
infect
rather
like
cgd
diagnost
workup
children
may
reveal
child
recurr
infect
initi
receiv
diagnosi
defici
subsequ
shown
phenotyp
xlink
cgd
disord
higher
incid
mediterranean
countri
asia
japan
indonesia
ascertain
novel
screen
kit
low
newborn
tehran
iran
within
framework
oxygendepend
kill
defect
hereditari
myeloperoxidas
defici
mpo
common
neutrophil
biochem
defect
play
import
role
host
defens
mechan
microbi
diseas
neutrophil
disord
character
lack
mpo
activ
specul
associ
decreas
level
immun
mpo
unusu
accompani
specif
patholog
ar
transmit
appear
far
common
previous
suspect
partial
defici
total
defici
disord
preval
record
entir
healthi
patient
therefor
case
random
laboratori
find
addit
three
alreadyknown
mutat
genet
character
italian
popul
show
presenc
six
novel
mutat
four
missens
mutat
delet
adenin
within
exon
mutat
within
splice
site
intron
c
delet
caus
shift
read
frame
occurr
prematur
stop
codon
within
propeptid
activ
cryptic
splice
site
locat
upstream
authent
splice
site
caus
shift
read
frame
may
lead
gener
abnorm
mpo
precursor
lack
enzymat
activ
japanes
patient
complet
mpo
defici
neutrophil
function
analysi
reveal
mpo
activ
alkalin
phosphatas
monocyt
function
alter
second
individu
suggest
cebph
play
critic
role
monocytemacrophag
develop
human
implic
abnorm
monocytesmacrophag
neutrophil
onset
develop
disord
sever
congenit
neutropenia
scn
cyclic
neutropenia
disord
neutrophil
product
predispos
patient
recurr
bacteri
infect
recent
mutat
gene
encod
neutrophil
elastas
indic
common
caus
scn
well
caus
autosom
domin
cyclic
neutropenia
defici
lead
regularli
fluctuat
level
neutrophil
linkag
analysi
affect
pedigre
shown
cyclic
neutropenia
sporad
case
diseas
due
mutat
gene
locat
enzym
synthes
neutrophil
precursor
earli
process
primari
granul
format
mutat
gene
detect
one
three
appar
autosom
domin
kindr
famili
scn
mutat
identifi
appar
ar
famili
result
fit
show
mutat
found
five
scn
famili
suggest
case
autosom
domin
scn
caus
mutat
howev
high
frequenc
het
mutat
neutrophil
elastas
gene
sporad
scn
confirm
previou
report
consid
four
novel
mutat
lowfrequ
polymorph
detect
nearli
case
sporad
scn
may
result
de
novo
het
mutat
recurr
scn
absolut
neutrophil
count
cellsmm
l
oscil
approxim
period
circul
neutrophil
vari
almost
normal
number
zero
patient
cyclic
neutropenia
howev
cycl
rang
day
children
refer
period
pid
follow
cyclic
neutropenia
shwachmandiamond
syndrom
kostmann
syndrom
syndrom
mean
absolut
neutrophil
count
children
cellsmm
rang
first
visit
children
first
experienc
symptom
infect
suggest
neutropenia
median
age
month
rang
month
year
also
suffer
oral
ulcer
otiti
pneumonia
diarrhea
cutan
abscess
oral
candidiasi
fever
stomat
periodont
skin
infect
occur
period
neutrophil
count
low
significantli
diminish
slightli
elev
superoxid
product
mutat
analysi
patient
reveal
glycin
serin
substitut
exon
region
granulocyt
without
mpo
kill
candida
subject
presum
carrier
extens
mutat
associ
diseas
present
sever
recurr
candida
infect
mpo
defect
diagnos
via
cytochem
investig
quantit
count
enzym
level
neutrophilspecif
granul
defici
rare
autosom
domin
disord
character
recurr
pyogen
infect
defect
neutrophil
chemotaxi
bactericid
activ
lack
neutrophil
secondari
granul
protein
markedli
decreas
level
mrna
express
bactericidalpermeabilityincreas
bpi
protein
activ
factor
defensin
patient
suggest
role
ccaatenhanc
bind
protein
gene
earlier
phase
myeloid
differenti
program
member
leucin
zipper
famili
transcript
factor
express
primarili
myeloid
cell
recess
mutat
gene
describ
one
patient
analys
locu
indic
disord
could
result
hz
recess
inherit
mutant
allel
ancestor
share
parent
loss
cebph
function
primari
genet
defect
diseas
second
individu
lack
function
cebph
analysi
peripher
blood
leukocyt
reveal
aberr
express
proband
cell
male
patient
lack
neutrophilspecif
granul
die
complic
pneumonia
age
neutrophilspecif
granul
contain
import
microbicid
compon
tabl
among
defici
oxygenindepend
kill
ar
defect
character
sever
recurr
bacteri
deeptissu
skin
infect
without
patient
show
increas
suscept
particular
pathogen
defect
chemotaxi
disaggreg
receptor
upregul
defici
oxidoreduct
microorganismkil
mechan
also
describ
markedli
decreas
level
mrna
express
bactericid
permeabilityincreas
bpi
protein
activ
factor
defensin
patient
suggest
role
cebph
earlier
phase
myeloid
differenti
program
defect
identifi
blood
test
color
wright
reactiv
polymorphonucl
present
specif
granul
normal
contain
lactoferrin
morpholog
point
view
nuclei
appear
bilob
nuclear
membran
may
show
introand
extrovers
also
possibl
identifi
membran
lack
cyclic
neutropenia
autosom
domin
disord
cyclic
hematopoiesi
caus
interv
neutropenia
suscept
opportunist
infect
nine
famili
whose
children
display
typic
blood
pattern
pedigre
confirm
domin
inherit
without
evid
heterogen
decreas
penetr
three
pedigre
suggest
new
mutat
wide
spectrum
symptom
sever
rang
asymptomat
lifethreaten
ill
observ
within
nine
famili
phenotyp
chang
age
children
display
typic
neutrophil
cycl
symptom
mucos
ulcer
lymphadenopathi
infect
patient
usual
asymptomat
period
sever
neutropenia
recurr
overwhelm
infect
inflamm
ulcer
occur
patient
lead
signific
chronic
morbid
sever
neutropenia
shown
children
moder
mild
children
leukopenia
anemia
thrombocytopenia
monocytosi
followup
respiratori
infect
develop
oral
manifest
children
common
infect
descend
order
frequenc
otiti
media
abscess
pneumonia
oral
ulcer
acut
diarrhea
cutan
infect
oral
candidiasi
periodontit
sinus
cystiti
conjunct
mening
osteomyel
less
frequent
observ
hepatomegali
also
detect
children
splenomegali
one
children
die
recurr
infect
therefor
recurr
infect
alway
deserv
evalu
detect
disord
abdomin
pain
must
assess
aggress
high
frequenc
clostridium
infect
period
sever
neutropenia
cours
scn
bm
show
lack
matur
granulocyt
precursor
beyond
myelocyt
myeloid
hyperplasia
remaind
cycl
occasion
reduct
sever
neutropenia
accompani
infect
time
complet
clear
symptom
signific
increas
qualiti
life
noteworthi
children
howev
diseas
commonli
describ
benign
four
children
three
nine
famili
die
clostridium
e
coli
coliti
document
need
urgent
evalu
abdomin
pain
pediatr
cyclic
neutropenia
effect
treat
rhugcsf
recombin
human
gcsf
usual
dose
mgkgday
median
dose
mgkgday
twice
weekli
month
typic
children
note
earli
infanc
persist
scn
absolut
neutrophil
count
l
last
month
year
children
age
day
month
initi
lowest
median
absolut
neutrophil
count
l
l
respect
usual
children
suffer
longterm
recurr
bacteri
infect
matur
arrest
myelopoiesi
promyelocytemyelocyt
stage
bm
develop
diseas
begin
year
life
infecti
complic
includ
cellul
perirect
abscess
periton
stomat
mening
commonli
result
infect
aureu
e
coli
pseudomona
aeruginosa
number
circul
monocyt
eosinophil
often
increas
miss
import
cell
defens
bacteri
infect
neutrophil
granulocyt
children
suffer
episod
sever
often
lifethreaten
bacteri
infect
spend
mani
day
hospit
requir
iv
antibiot
treatment
recurr
bacteri
infect
lead
irrevers
tissu
damag
exampl
lung
requir
often
disabl
surgic
intervent
high
incid
signific
bone
miner
loss
seen
children
scn
presenc
qualit
quantit
abnorm
primit
myeloid
progenitor
cell
express
gcsfr
may
play
import
role
impair
granulopoiesi
patient
thu
nearli
patient
respons
pharmacolog
dose
rhugcsf
neutrophil
count
rise
infect
rate
fall
mortal
reduc
sinc
introduct
rhugcsf
children
enjoy
normal
life
span
greatli
improv
qualiti
life
although
still
problem
infect
especi
chronic
gingiv
periodont
like
bone
loss
caus
pathophysiolog
featur
underli
diseas
possibl
rhugcsf
acceler
bone
miner
loss
prolong
administr
rhugcsf
dose
ukg
bw
twice
daili
may
associ
increas
bone
resorpt
mediat
osteoclast
activ
lead
bone
loss
children
result
osteopenia
success
manag
antiresorpt
bisphosphon
therapi
signific
improv
bone
densiti
child
maintain
longterm
rhugcsf
therapi
develop
acut
myelogen
leukemia
associ
gcsfr
mutationaft
undergon
success
allogen
bmt
mutat
gcsfr
mutat
becam
undetect
pcr
shwachman
syndrom
rare
ar
condit
character
pancreat
insuffici
reduc
mobil
neutrophil
chemotaxi
cyclic
neutropenia
thrombocytopenia
metaphys
dysostosi
delay
growth
recurr
pyogen
infect
two
case
associ
isol
gh
defici
addit
metaphys
chondrodysplasia
neutropenia
panpoor
absent
granuloma
format
salmonella
certain
viral
infect
hsv
cmv
parainfluenza
respiratori
syncyti
viru
rsv
also
seen
patient
bear
defici
present
gross
mutat
truncat
protein
prevent
express
give
rise
sever
mycobacteri
infect
frequent
fatal
outcom
mortal
children
high
infect
sever
recurr
girl
receiv
bmt
point
mutat
may
fatal
individu
probabl
hz
mutat
die
mening
due
mycobacterium
bovi
hz
missens
mutat
identifi
two
sibl
respond
low
intermedi
concentr
yet
respond
high
ifng
concentr
probabl
reduc
affin
ligand
otherwis
mutat
result
normal
surfac
express
bind
ifng
domin
delet
gene
report
femal
patient
hz
delet
exon
develop
postvaccin
dissemin
bcg
infect
ar
form
partial
defici
report
patient
unrel
kindr
suscept
mycobacteri
infect
girl
defici
also
recurr
mycobacteri
infect
liver
cirrhosi
portal
hypertens
receiv
red
celldeplet
bmt
hlaident
sister
transplant
cours
unev
year
later
child
remain
excel
clinic
condit
free
mycobacteri
infect
complet
defici
found
child
due
hz
dinucleotid
delet
result
prematur
stop
codon
protein
extracellular
domain
gene
defect
emphas
critic
role
ifng
play
host
defens
mycobacteria
girl
bcg
salmonella
enteritidi
infect
hz
recess
delet
subunit
il
lead
complet
il
defici
report
larg
hz
delet
within
il
subunit
gene
found
preclud
il
compos
subunit
function
express
activ
dc
phagocyt
net
result
markedli
impair
ifng
product
lymphocyt
howev
addit
recombin
exogen
il
assay
abl
restor
normal
ifng
product
vitro
girl
suffer
wellorgan
granuloma
possibl
due
residu
il
independ
ifng
product
anoth
kindr
two
sibl
one
unrel
patient
carri
larg
delet
also
accompani
dissemin
infect
femal
repeatedli
hospit
sinc
age
week
recurr
episod
pneumococc
pneumonia
sepsi
infect
absenc
creatic
exocrin
insuffici
find
children
note
variabl
extrem
shorten
cup
deform
rib
metaphys
widen
hypoplasia
iliac
bone
increas
echogen
pancrea
chang
size
recurr
infect
begin
year
life
commonli
involv
sinus
lung
bone
skin
urinari
tract
neutropenia
either
cyclic
intermitt
occur
patient
patient
also
pancytopenia
immun
function
may
involv
syndrom
includ
mark
panhgg
especi
iga
normalincreas
cellular
immun
depress
humor
nk
cell
immun
patient
diagnos
infanc
signific
growth
improv
decreas
frequenc
infect
observ
time
addit
improv
normal
exocrin
pancreat
function
continu
spectrum
system
bcg
infect
local
recurr
nontubercul
mycobacteri
infect
cover
clinic
featur
affect
children
recent
help
identifi
sever
genet
defect
tcell
pathway
differ
type
mutat
four
gene
il
il
form
axi
reveal
allel
nonallel
heterogen
result
differ
disord
whose
common
pathogen
pathway
impair
ifngmedi
immun
sever
children
report
present
new
kind
hereditari
id
sever
andor
recurr
infect
caus
one
microorgan
famili
opposit
patient
classic
pid
five
new
syndrom
may
encompass
children
genet
predisposit
infecti
diseas
ifngil
axi
impair
host
becom
highli
suscept
infect
organ
replic
intracellularli
suscept
mycobacteri
diseas
signal
transduc
activ
defici
predispos
viral
diseas
nemo
il
ractiv
defici
predispos
infect
caus
pyogen
bacteria
pid
encompass
sever
defect
complet
partial
ar
defici
complet
partial
ad
defici
ifng
cellular
respons
induc
essenti
control
mycobacteri
infect
patient
ar
mutat
lead
complet
loss
express
sever
phenotyp
present
earli
life
dissemin
sever
infect
especi
receiv
bcg
vaccin
fever
exhibit
il
defici
associ
abnorm
il
gene
although
present
ifng
reduc
genet
lack
il
surfac
express
predispos
sever
infect
pathogen
mycobacteria
salmonella
caus
strongli
decreas
complet
abrog
ifng
product
defici
may
complet
well
partial
sever
patient
featur
report
three
unrel
individu
sever
idiopath
mycobacteri
salmonella
infect
found
lack
il
chain
express
il
sequenc
analysi
reveal
genet
mutat
result
prematur
stop
codon
extracellular
domain
patient
sever
infect
multipl
advers
drug
reaction
cell
unabl
produc
ifng
prolifer
respons
il
despit
express
wildtyp
il
il
defect
il
r
signal
lead
low
tcell
nkcell
ifng
product
il
il
chain
associ
ar
defici
suscept
mycobacteria
salmonella
infect
form
ad
ar
mutant
fail
restor
ifng
product
il
transgen
cell
activ
il
lost
impair
specif
il
activ
alon
suffici
il
induc
ifng
product
prolifer
two
unrel
infant
hz
respect
mutat
suffer
mycobacteri
diseas
unlik
patient
ifngr
defici
die
viral
diseas
complement
integr
part
humor
defens
system
infect
also
promot
inflammatori
process
fig
complement
defici
found
dutch
patient
period
year
studi
blood
donor
preval
may
gener
popul
congenit
defici
describ
protein
compos
tabl
usual
follow
ar
model
properdin
defici
complement
defici
xlink
het
easili
identifi
relev
compon
present
serum
concentr
lack
one
compon
hz
level
serolog
involv
blockag
enzym
releas
absenc
hemolyt
activ
control
protein
caus
uncontrol
activ
consum
factor
object
control
variou
way
also
success
compon
nonfunct
variant
observ
defici
often
associ
probabl
map
contigu
gene
chromosom
b
gene
situat
short
limb
chromosom
constitut
along
other
hla
class
iii
chap
codifi
chromosom
similar
structur
show
differ
structur
molecul
consist
three
b
g
chain
unit
form
two
subunit
ag
b
dictat
differ
gene
altern
pathway
defici
extrem
rare
complement
defici
accompani
increas
frequenc
infecti
patholog
although
rare
come
across
individu
appar
good
health
case
hereditari
defici
also
frequent
teen
young
adult
autoimmun
manifest
chap
classic
pathway
defici
often
associ
slelik
diseas
system
lupu
erythematosu
id
earli
compon
complement
associ
risk
infect
caus
encapsul
bacteria
streptococcu
pneumonia
haemophilu
influenza
type
b
well
meningococci
incid
sle
patient
defici
respect
partial
defici
also
associ
sle
patient
sle
exhibit
defici
sever
compon
associ
develop
membranoprolif
glomerulonephr
tabl
altern
pathway
id
infect
recogn
pyogen
common
etiolog
agent
final
common
pathway
id
properdin
p
associ
recurr
invas
infect
neisseria
n
gonorrhoea
n
meningitidi
gramneg
bacteria
asplenia
agammaglobulinemia
estim
frequenc
mening
subject
hz
defici
final
pathway
higher
nonid
individu
characterist
appear
associ
patient
complement
defici
meningococc
diseas
frequent
recurr
episod
older
age
first
onset
lower
mortal
compar
patient
normal
complement
preval
male
patient
defici
describ
defici
two
case
select
complet
defici
girl
complex
aid
includ
slelik
syndrom
hashimoto
thyroid
autoimmun
hepat
report
exonspecif
amplif
genom
dna
pcr
follow
direct
sequenc
analysi
reveal
mz
nonsens
mutat
gene
exon
xii
codon
parent
het
mutat
defici
one
protein
suffici
block
classic
pathway
activ
defici
result
consequ
nonsynthesi
unlik
hz
defici
rare
caus
nonexpress
allel
matern
patern
allel
occur
due
punctiform
mutat
gene
delet
gene
alter
prevent
gene
transcript
two
gene
polymorph
like
b
factor
bf
polymorph
variant
protein
rare
differ
allel
identifi
moment
moreov
two
loci
null
allel
quantiti
codifi
phenotyp
although
often
present
gener
popul
caucasian
child
suffer
sever
bout
pneumonia
caus
respiratori
virus
eight
episod
acut
otiti
media
prolong
respiratori
urinari
tract
infect
molecular
studi
gene
region
reveal
hz
delet
hla
class
iii
gener
total
defici
case
amount
case
remain
molecul
malfunct
crossreact
nativ
molecul
defici
usual
combin
due
contigu
two
gene
typic
patient
absent
level
reduc
affect
patient
suffer
slelik
syndrom
sporad
extend
predisposit
infect
associ
symptom
defici
slelik
syndrom
rheumat
diseas
infect
sever
children
suffer
mening
recurr
septicemia
recurr
otiti
media
pneumonia
stomat
two
die
mening
septicemia
incid
base
data
inherit
alway
ar
except
defici
autosom
domin
factor
p
defici
autosom
recess
xlink
data
gn
glomerulonephr
jra
juvenil
rheumatoid
arthriti
flank
region
moreov
case
allel
relat
gene
delet
within
bf
haplotyp
case
allel
relat
gene
delet
within
haplotyp
null
allel
incid
elev
popul
express
gene
lack
allel
elev
number
probabl
deriv
mark
similitud
two
gene
facilit
unequ
crossov
crossov
hla
modul
express
three
allel
one
vice
versa
allel
spread
amplifi
risk
contract
sle
juvenil
ra
jra
hz
defici
common
caucasian
popul
incid
vari
wherea
het
carrier
rate
usual
found
bf
haplotyp
context
due
consider
rariti
could
assum
predict
valu
two
differ
type
defici
known
type
synthesi
defici
due
protein
nontransl
type
ii
select
absenc
secret
synthesi
therefor
level
normal
valu
het
nonfunct
gene
complement
profil
character
serum
concentr
equal
normal
valu
asymptomat
half
exhibit
frequent
infect
quit
suffer
sle
correl
syndrom
het
defici
associ
delet
gene
type
mainli
within
bf
haplotyp
certain
number
case
defici
accompani
partial
bf
malfunct
genet
close
hz
also
defici
function
altern
pathway
possibl
defici
like
quit
common
one
may
alway
report
literatur
total
number
case
therefor
underestim
real
preval
also
found
children
defici
defici
must
suspect
patient
present
pneumococc
infect
age
year
predispos
sle
express
particular
genet
associ
caus
gene
local
r
defici
also
caus
sle
situat
mention
outsid
hla
system
molecular
base
pid
appear
heterogen
gene
exist
differ
allel
form
reduc
function
one
must
rememb
import
role
immun
respons
also
far
apc
b
cell
concern
well
defens
role
play
innat
immun
along
sinc
pathway
converg
cleavag
activ
way
defect
correct
furthermor
opson
power
greatli
defici
chemotaxi
therefor
patient
affect
hz
defici
mostli
present
clinic
symptom
total
similar
congenit
hgg
sever
recurr
infect
time
symptom
cic
diseas
although
id
sever
patient
appar
remain
good
health
syndrom
may
also
time
becom
less
sever
probabl
due
higher
number
immun
experi
allow
better
effector
function
antibodi
reaction
mediat
fc
receptor
protein
defect
noninfect
nigerian
children
proteinenergi
malnutrit
pem
rose
significantli
presenc
bacteri
infect
thu
share
valu
found
healthi
control
clinic
express
defici
differ
defici
discuss
clinic
consequ
absent
anaphylotoxin
unclear
onefourth
patient
asymptomat
caucasian
incid
defici
associ
rare
reflect
close
genet
proxim
pertin
gene
defici
patient
lack
one
compon
experi
least
one
sever
episod
neisseria
infect
one
aid
rare
europ
defici
second
common
complement
defici
japanes
italian
children
preval
identifi
also
healthi
sibl
japan
defici
associ
meningococc
mening
neisseria
infect
highli
inbr
arab
popul
defici
associ
mutat
also
preval
among
isra
jew
moroccan
ancestri
total
defici
protein
inherit
ar
trait
describ
young
patient
hemolyticurem
syndrom
one
case
itali
whose
parent
first
cousin
among
rel
proband
studi
encompass
gener
ten
low
factor
h
level
includ
two
children
indic
het
factor
h
defici
h
defici
result
uncontrol
breakdown
deplet
bf
p
compon
decreas
vari
degre
found
plasma
trace
activ
molecul
inherit
factor
defici
moment
uncertain
tabl
partial
defici
normal
concentr
describ
two
mz
twin
total
defici
one
male
defici
serolog
character
nonfunction
altern
pathway
clinic
accompani
increas
suscept
neisseria
infect
lead
us
emphas
altern
pathway
signific
substanti
mean
defens
broad
spectrum
damag
action
caus
bacteri
infect
properdin
defici
one
inherit
characterist
link
chromosom
x
affect
male
moment
case
describ
defici
materi
total
p
absenc
level
reduc
normal
level
howev
show
alter
function
activ
specif
research
shown
remark
reduct
b
titer
repres
protein
consequ
heighten
consumpt
due
altern
pathway
spontan
activ
male
affect
septic
episod
caus
neisseria
sometim
fulmin
onset
even
occur
year
life
evid
increas
suscept
cic
diseas
infect
caus
organ
thu
impli
function
altern
pathway
particularli
import
defens
infect
correctli
identifi
children
complement
abnorm
import
worthwhil
follow
factor
present
id
repeat
unusu
infect
organ
fh
unusu
cours
ill
etc
repeat
neisseri
infect
infect
unusu
serogroup
fulmin
diseas
male
p
defici
coexist
angioedema
autoimmun
connect
tissu
disord
two
form
defici
map
chromosom
subunit
involv
present
serum
also
reduc
level
accompani
alter
function
one
involv
defici
differ
characterist
due
divers
associ
b
ag
chain
therefor
caucasian
defici
lack
b
chain
color
patient
lack
g
chain
defici
poorli
consid
often
asymptomat
howev
japan
incid
case
present
meningococc
mening
congenit
defici
common
among
japanes
repres
defici
tabl
case
congenit
defici
report
distribut
unevenli
variou
ethnic
group
defici
preval
color
patient
defici
appear
common
caucasian
analysi
publish
studi
show
patient
sporad
meningococc
infect
may
defici
clinic
pattern
overlap
common
complement
defici
defici
inhibitor
respons
hereditari
angioedema
caus
symptom
het
chap
least
case
factor
defici
known
autosom
codomin
transmiss
parent
show
normal
complement
level
factor
h
defici
serolog
one
altern
pathway
activ
due
noncatabol
continu
form
convers
sever
defici
level
exceed
normal
valu
hz
addit
subsequ
pyogen
infect
defici
cutan
rash
urticaria
caus
massiv
releas
histamin
proinflammatori
cellular
product
anaphylotox
fragment
report
fact
child
initi
period
life
experi
certain
number
urti
lrti
within
norm
rri
mainli
caus
immunolog
immatur
inexperi
transient
typic
symptom
outlin
difficult
defin
preval
also
littl
known
id
children
basic
patholog
present
instead
encourag
recurr
infect
although
distinct
infect
associ
diseas
import
childhood
infect
might
key
role
stimul
matur
immun
system
microbi
burden
earli
life
invok
protect
factor
wheez
asthma
chap
preschoolag
children
especi
high
frequenc
vri
three
eight
infect
per
year
vri
per
year
rate
children
age
children
compar
children
age
age
rri
may
defin
six
episod
urti
andor
lrti
previou
year
base
age
episod
per
year
age
episod
per
year
age
sever
risk
factor
influenc
onset
recurr
infect
clear
younger
child
hesh
may
fall
ill
also
relat
serum
ig
level
tabl
dogma
primari
secondari
respons
also
may
appli
infect
least
caus
rotaviru
confer
consider
protect
variou
infecti
event
children
age
environment
factor
absenc
basic
patholog
import
also
obviou
crowd
environ
child
live
probabl
infect
becom
addit
number
sibl
factor
socioeconom
statu
age
preschool
children
contact
outsid
person
especi
babysitt
earli
social
contact
exposur
passiv
smoke
indoor
outdoor
pollut
may
found
relat
hygien
hypothesi
chap
howev
daycar
attend
consid
indic
exposur
respiratori
pathogen
presenc
sibl
increas
risk
urti
preschool
children
age
year
life
children
fha
among
children
fha
protect
effect
day
care
attend
earli
life
develop
atopi
begin
year
wheez
may
observ
year
particular
eas
smoke
parent
andor
rel
fall
ill
influenza
known
time
extent
children
live
affect
rri
tabl
impact
rri
incid
relat
children
kindergarten
reflect
significantli
increas
morbid
observ
babi
age
month
year
go
daycar
show
number
sever
longer
last
infect
per
year
incid
children
stay
home
compar
kindergarten
increas
ome
persist
chap
children
expos
cigarett
smoke
risk
increas
lrti
equal
episod
respiratori
infect
year
studi
environment
pollut
identifi
damag
agent
conclus
data
fine
particl
suspens
pollut
deriv
avail
prove
significantli
increas
risk
infantil
rri
tabl
indic
reduc
immun
defens
rti
provok
alter
epithelium
lymph
node
cell
neg
effect
mucociliari
clearanc
macrophag
biolog
role
play
domest
pollut
deriv
home
ascertain
relat
cook
smoke
releas
combust
use
wood
heat
lead
develop
radiat
caus
air
dri
turn
caus
potenti
infect
particl
remain
suspens
pollut
increasingli
respons
indoor
pollut
chap
although
level
micropollut
easili
ascertain
signific
associ
acut
rri
condit
polypnea
dyspnea
report
especi
yearold
children
children
capac
evok
adequ
respons
genet
control
howev
commonli
known
parent
sibl
suffer
similar
ill
children
subject
physiolog
immatur
immun
system
vri
easili
caus
infecti
episod
import
factor
consid
presenc
recurr
incomplet
clear
condit
predispos
factor
relat
basic
patholog
deriv
perinat
factor
common
prematur
babi
lead
respiratori
tract
alter
consequ
bronchopulmonari
dysplasia
anatom
anomali
cystic
fibrosi
becom
recurr
pneumonia
adenoid
caus
otiti
ome
congenit
ciliari
dyskinesia
humor
defici
pid
character
recurr
sinopulmonari
infect
tabl
virus
princip
etiolog
agent
novel
member
coronaviru
famili
character
associ
case
sar
sever
acut
respiratori
syndrom
phylogenet
analys
sequenc
comparison
show
sarscoronaviru
close
relat
previous
character
coronavirus
investig
studi
overal
preval
agerel
differ
children
age
fig
age
fig
rsv
rhinoviru
differ
impact
first
group
vs
influenza
virus
second
group
incid
young
children
higher
age
rsv
caus
bronchiol
breastf
babi
higher
frequenc
younger
child
tabl
rhiniti
older
sibl
even
infecti
agent
neglect
time
ureaplasma
urealyticum
caus
lung
patholog
younger
children
spare
year
old
bacteria
commonli
involv
streptococcu
pyogen
pharynx
larynx
haemophilu
complement
defici
fluenza
middl
ear
larynx
reach
epiglotti
streptococcu
pneumonia
middl
ear
often
secondari
bacteri
infect
complic
caus
vri
certainli
contribut
recurr
infect
andor
onset
chronic
chap
report
sever
studi
conclud
earli
infect
may
protect
atopi
develop
hygien
hypothesi
must
distinguish
pid
outlin
pseudoid
children
rri
summar
aforement
sever
recurr
lrti
sinus
princip
clinic
manifest
children
affect
defici
preval
involv
humor
immun
tabl
children
fall
ill
first
week
live
often
contract
infect
caus
opportunist
agent
fungi
protozoa
virus
month
go
also
affect
malnutrit
failur
thrive
episod
affect
airway
particularli
common
cellular
combin
id
tend
becom
longer
sever
especi
complic
pneumonia
chronic
disord
sinus
bronchiectasi
sinobronchi
syndrom
rare
interstiti
pneumonia
case
caus
pneumocysti
carinii
result
tachypnea
lung
hyperinfl
infect
support
herp
simplex
ebv
cmv
also
common
male
xlp
exhibit
defici
respons
ebv
sever
recurr
sinopulmonari
hige
ata
infect
well
sever
rri
cgd
complement
defici
lad
v
must
also
born
mind
case
recurr
pneumonia
warn
signal
rule
pediatr
case
pid
second
import
manifest
chronic
diarrhea
case
infect
caus
rotaviru
enteroviru
among
echo
giardia
lamblia
salmonella
campylobact
also
caus
chronic
enter
infect
malabsorpt
resist
treatment
ascrib
cryptosporidium
rri
common
children
reflect
immatur
immun
system
encount
environment
antigen
development
delay
first
year
life
foster
develop
rri
thu
rri
part
growingup
process
child
consequ
rri
profound
sometim
protract
alter
differ
immun
defens
mechan
place
child
undefend
posit
similar
condit
observ
children
pid
compromis
phagocyt
lymphocyt
nk
cell
antibodi
product
il
everi
occas
respons
virus
infect
develop
limit
surfac
mucou
cell
spread
cell
cell
due
contigu
virem
stage
absent
remain
margin
incub
period
therefor
brief
normal
day
consequ
immun
respons
may
capabl
ensur
protect
function
interven
partial
clarifi
potenti
unlimit
number
infecti
episod
pathogenet
point
view
viru
work
trigger
develop
ige
allerg
sensit
andor
damag
immun
structur
first
case
known
experiment
infect
mice
rsv
capabl
significantli
increas
absorpt
ovalbumin
ova
administ
aerosol
igg
ige
antiova
siga
fig
increas
synthesi
ige
specif
igg
ragwe
also
administ
aerosol
result
major
infant
becom
infect
rsv
although
lrti
develop
approxim
subsequ
experi
recurr
acut
asthma
vri
mechan
vri
induc
atop
sensit
experiment
model
identifi
antigen
penetr
sige
synthesi
studi
show
virus
increas
mucos
permeabl
modul
antigen
uptak
alter
antigen
process
mucosa
result
igesuppressor
tcell
depress
ifngmodul
histamin
releas
increas
mucos
permeabl
probabl
immun
defici
secondari
vri
mani
virus
capabl
induc
transient
lack
nk
cell
front
line
defens
viral
infect
alter
product
il
factor
activ
phagocyt
associ
appear
signific
unclear
whether
defici
primari
secondari
viral
infect
basic
question
potenti
therapeut
consequ
therefor
remain
unansw
probabl
destin
remain
sophist
test
avail
clarifi
issu
although
nkcell
reduct
children
corrobor
first
hypothesi
recent
data
emphas
import
defens
activ
cytotox
cell
differ
il
includ
il
il
il
activ
antivir
defens
infect
cell
express
surfac
viral
antigen
process
associ
hla
class
molecul
cytotox
take
care
kill
cell
normal
activ
viru
solubl
factor
releas
infect
cell
mediat
cellular
lyse
recogn
hla
class
antigen
cell
howev
apc
macrophag
parasit
viru
consequ
reduc
chemotaxi
microbicid
activ
particular
capac
cooper
cell
consid
macrophag
may
evolv
specif
mechan
direct
tcell
develop
toward
sinc
cmi
solv
infect
clear
dysfunct
appear
insuffici
nk
cell
activ
inadequ
develop
respons
infect
ifng
produc
direct
consequ
infect
probabl
il
andor
il
stimul
nearbi
cell
block
nucleic
acid
transcript
therefor
viral
replic
prevent
infect
cell
viru
spread
due
contigu
therefor
ifng
speciesspecif
antivir
activ
take
place
first
stage
infect
preced
antibodi
respons
germ
capsular
polysaccharid
particularli
defici
age
although
encount
germ
abund
period
time
still
remain
evalu
howev
select
children
although
normal
immunolog
point
view
may
defici
antibodi
respons
even
age
percentag
modif
humor
cmi
therefor
antibodi
synthesi
phagocyt
neutrophil
function
also
lymphocyt
relat
il
also
possibl
hypothes
persist
vri
capabl
induc
activ
antigen
superantigen
cell
il
help
induc
virusspecif
produc
il
recruit
eosinophil
respiratori
tract
thu
reduc
ifng
secret
thu
may
increas
interact
ige
mast
cell
subject
immunoregulatori
alter
due
mark
lymphoprolif
respons
elabor
il
consequ
amplifi
ige
product
respiratori
tract
ige
respons
thought
lead
greater
product
bronchoconstrictor
mediat
effector
cell
viral
infect
may
induc
cell
releas
histamin
also
known
humor
defici
especi
iga
often
open
way
gramposit
germ
caus
viral
bacteri
infect
therebi
complet
circl
interestingli
children
least
signific
product
antigenspecif
salivari
iga
klebsiella
pneumonia
even
alter
transient
aspecif
children
rri
occurr
persist
number
month
year
even
longer
lead
believ
immunosuppress
mechan
set
first
episod
occas
sever
profound
last
consequ
immun
function
occur
normal
peer
least
one
physiciandiagnos
lrti
year
life
significantli
associ
recurr
wheez
asthma
base
exclus
predisposit
children
contract
rri
nk
cell
reduct
immun
defici
relat
global
lymphocyt
popul
ratio
unbalanc
toward
cell
preval
children
express
cough
compar
bronchial
hyperreact
bhr
tcell
defici
children
humor
anomali
includ
consider
spontan
product
il
il
gener
th
phenotyp
altern
express
il
similarli
feasibl
virusspecif
depriv
cytolyt
activ
convert
cell
il
present
cmi
children
consist
transient
tcell
numer
function
depress
coincid
defici
il
necessari
activ
prolifer
differenti
viru
toxic
effect
also
act
directli
cell
incit
rough
structur
modif
includ
giant
polynucl
cell
jeopard
home
recircul
capac
point
immunosuppress
affect
specif
lymphocyt
particular
viru
thu
favor
attack
organ
condit
immunosuppress
occur
also
result
superantigen
sa
orchestr
stimul
larg
numnonreact
children
rise
iga
andor
igg
subclass
defici
children
low
antipneumococcu
igg
antibodi
respons
total
absent
dysimmunoglobulinem
virtual
absenc
iga
igg
confirm
previou
data
iga
igg
defici
children
show
clinic
pattern
elev
suscept
pneumonia
infect
von
waldey
ring
nalt
signific
constitu
immun
respons
resist
naltdepend
infect
among
consequ
chronic
adenotonsil
tabl
statist
signific
decreas
ig
level
includ
siga
must
evalu
eventu
relat
rri
complic
chap
igg
subclass
defici
present
children
chronic
andor
sever
asthma
associ
sigad
children
affect
asthma
sever
rri
chronic
nonallerg
respiratori
clinic
symptom
children
sigad
ata
cvid
scid
healthi
subject
antiviru
antibodi
gener
belong
igg
igg
isotyp
igg
protect
microb
polysaccharid
antigen
pneumonia
group
type
b
h
influenza
tabl
show
normal
valu
igg
subclass
subject
age
unlik
total
igg
concentr
igg
igg
reach
normal
level
within
year
igg
matur
slowli
ensur
effect
antibodi
respons
year
igg
develop
even
slowli
variou
author
believ
role
play
igg
subclass
uniqu
vital
defend
infect
igg
defici
associ
increas
suscept
infect
bacteria
express
capsular
polysaccharid
pneumococci
meningococci
h
influenza
bordetella
pertussi
etc
well
factor
capabl
set
inflamm
igg
defici
instead
seem
associ
mark
predisposit
rri
howev
undetect
igg
subclass
level
common
find
normal
individu
accur
detect
low
level
igg
technic
difficult
achiev
babi
age
month
level
circul
lymphocyt
secret
four
subclass
higher
number
adult
therefor
capac
produc
antibodi
exist
well
full
humor
respons
develop
subnorm
igg
subclass
concentr
especi
igg
also
observ
healthi
children
present
increas
suscept
infect
low
subclass
level
necessarili
indic
subject
experi
immun
disord
exclus
link
normal
concentr
guarante
child
spare
complic
subject
observ
normal
igg
level
recurr
infect
subclass
defici
often
form
type
antibodi
igg
subclass
determin
indic
humor
level
restrict
molecul
characterist
children
unlik
adult
even
though
research
carri
use
method
two
studi
interest
hint
come
studi
involv
children
rri
children
age
confirm
diagnosi
suscept
infect
igg
subclass
defici
almost
concern
igg
sever
associ
children
select
igg
defici
statist
signific
compar
atop
control
without
rri
associ
much
welldefin
state
id
respiratori
tract
defens
mechan
defici
view
fact
rel
preval
subclass
secret
may
indic
role
mucos
defens
children
typic
symptom
recurr
infect
lymphadenopathi
failur
thrive
hgg
exhibit
low
igg
level
confirm
normal
level
total
igg
exclud
subclass
defici
cohort
young
babi
igg
defici
present
subject
howev
absenc
control
group
make
result
incompar
igg
subclass
defici
therefor
abl
induc
worsen
chronic
respiratori
symptom
allerg
nonallerg
children
especi
predispos
develop
affect
subject
sigad
time
defici
eventu
also
associ
iga
normal
conclus
transient
persist
iga
andor
igg
defici
report
small
percentag
asymptomat
children
even
iga
igg
subclass
alway
requir
normal
immun
respons
defici
may
predispos
rri
previous
illustr
chap
close
link
atopi
rri
known
confirm
observ
asthmat
children
higher
incid
rri
nonasthmat
sibl
known
rri
earli
period
life
play
role
develop
bhr
atopi
classic
studi
frick
et
al
allerg
children
sensit
propiti
rri
continu
observ
author
note
presenc
high
ige
level
posit
rast
histamin
releas
leukocyt
infect
cohort
asthmat
children
age
affect
week
pregnanc
possibl
evalu
immun
phenotyp
fetal
blood
wcc
whitecel
count
cb
differenti
count
use
detect
lymphopenia
commonli
present
infant
scid
howev
subset
analysi
flow
cytometri
necessari
enumer
b
nk
cell
subsequ
scid
diagnosi
suspect
overwhelm
opportunist
infect
occur
depend
whether
one
suspect
humor
cellular
innat
immun
defici
begin
algorithm
tabl
posit
infant
children
sign
laboratori
test
consult
howev
children
variabl
level
antibodi
id
may
end
differ
diagnosi
children
higm
present
initi
histori
increas
suscept
infect
includ
pneumocysti
carinii
pneumonia
children
pid
affect
phagocyt
rel
narrow
spectrum
diseasespecif
infect
aspergillosi
cgd
care
attent
microbiolog
laboratori
earli
cours
evalu
patient
suspect
pid
crucial
orient
workup
appropri
direct
male
newborn
refer
hospit
day
age
fever
hemodynam
failur
inflamm
syndrom
caus
pulmonari
infect
cultur
tracheal
bronchoalveolar
lavag
sampl
lung
biopsi
grew
posit
fumigatu
enabl
diagnosi
cgd
investig
whether
patient
undiagnos
id
could
identifi
divers
inpati
hospit
popul
score
algorithm
comput
screen
method
updat
basi
code
survey
discharg
diagnos
hospit
patient
period
time
thu
id
patient
identifi
eight
children
age
two
neutropenia
two
igg
defici
one
lad
one
dg
etc
also
suggest
includ
congenit
phagocyt
defect
differenti
diagnosi
recurr
bacteri
fungal
infect
child
congenit
complement
defici
suspect
level
even
one
compon
reduc
earli
diagnosi
essenti
choos
necessari
treatment
differenti
diagnosi
pid
emphas
differ
characterist
schemat
tabl
one
must
add
object
rariti
fh
child
gender
becom
import
subject
suffer
omenn
syndrom
sever
combin
cellular
id
screen
clinic
symptom
may
use
birth
first
month
birth
tabl
local
infect
multipl
id
child
usual
appear
ill
peripher
lymph
node
lymphat
rri
higher
incid
fh
posit
increas
ige
well
combin
iga
igg
defici
ige
hyperproduct
could
result
wellknown
associ
igg
subclass
ige
coregul
il
express
also
viruscaus
unbalanc
ratio
result
link
atopi
rri
confirm
state
chronic
inflamm
bhr
induc
allerg
sensit
ideal
substratum
adhes
chronic
evolut
bacteri
andor
viral
infect
specif
clinic
outlin
rri
contrari
symptom
extrem
vari
previous
mention
infect
caus
bacteria
virus
urti
common
age
last
month
children
experienc
one
bout
acut
otiti
media
one
pharyngotonsil
episod
contract
common
cold
rhiniti
weekli
monthli
children
period
maximum
exposur
due
biolog
immatur
immunolog
inexperi
suffer
one
episod
month
affect
differ
organ
system
well
lymphadenopathi
failur
thrive
capac
induc
bhr
normal
subject
worsen
symptom
alreadi
ill
precis
caus
vri
also
facilit
greater
penetr
inhal
viral
allergen
tabl
rri
turn
predispos
sinus
lower
ifng
level
produc
children
month
age
even
greater
comparison
made
children
rri
maxim
one
rri
followup
period
rhinovirusinduc
infect
tabl
take
appear
common
rhiniti
stimul
mastocyt
releas
histamin
contribut
bhr
develop
perspect
delay
reaction
differenti
featur
respiratori
infect
id
child
may
also
result
opportunist
pathogen
tabl
respiratori
infect
control
screen
humor
immun
reveal
low
ig
level
low
iga
level
sigad
children
last
year
increasingli
sophist
diagnost
techniqu
permit
prenat
diagnosi
mani
case
tabl
form
support
andor
mutat
diagnosi
even
pharyng
tissu
almost
impercept
serious
undernourish
appear
note
often
observ
children
scid
rri
observ
cmi
form
defici
g
e
chain
hla
class
ii
final
children
aid
seem
sever
gener
condit
diseas
paradigmat
exampl
hiv
overturn
lymphocyt
immun
defens
regard
opportunist
infect
case
pediatr
aid
hgg
indistinguish
pid
belong
differenti
diagnosi
sever
recurr
infect
first
month
birth
far
tih
concern
confirm
normal
presenc
b
lymphocyt
low
level
intrins
produc
ig
resolut
compar
agammaglobulinemia
articul
case
histori
often
identifi
familiar
rri
usual
absent
basic
patholog
frequent
predispos
environment
factor
tabl
among
passiv
cigarett
smoke
stand
maximum
preval
occur
first
year
life
first
contact
school
diseas
limit
time
usual
singl
locat
case
pseudoimmunodepress
child
clinic
normal
respect
ten
report
sarsinfect
children
hong
kong
fever
cough
runni
nose
complement
defici
later
pharyng
xray
visual
adenoid
tissu
cytokin
product
il
il
il
il
ifng
il
chromosom
fragil
ataxiatelangiectasia
bloom
syndrom
etc
data
ada
adenosinedeaminas
adcc
antibodi
depend
cellmedi
cytotox
ctl
cytotox
lymphocyt
ltt
lymphocyt
transform
test
pha
phytohemagglutinin
pma
phorbol
myrist
acet
pnp
purin
nucleosid
phosphorylas
ppd
purifi
protein
deriv
sar
seem
less
aggress
clinic
cours
younger
children
doubt
broad
spectrum
laboratori
test
avail
cbc
proteinemia
protidogram
serum
ig
level
secret
igg
subclass
tabl
immunoelectrophoresi
homogen
compon
kl
dosag
isohemagglutinin
five
natur
antibodi
sweat
test
strictli
select
case
also
lymphocyt
popul
subpopul
count
tabl
xray
paranas
sinus
analysi
lymphocyt
profil
sometim
show
number
defici
statist
differenti
found
children
affect
asthmat
patholog
howev
none
immunolog
defici
indic
tabl
characterist
pseudoimmunodepress
children
common
diagnost
method
may
capabl
reveal
defici
igg
subclass
select
igg
chanc
may
abnorm
igg
igg
level
exclud
normal
igg
serum
concentr
furthermor
distribut
igg
four
subclass
make
difficult
identifi
defici
simpli
measur
total
serum
igg
level
past
year
highli
specif
reagent
measur
individu
subclass
level
method
radial
immunodiffus
rid
aaaai
recommend
reli
subclass
level
especi
igg
level
seem
unmeasur
popul
rid
proven
sensit
elisa
use
cdc
atlanta
shown
normal
children
valu
normal
least
one
subclass
similar
defici
present
children
rri
recent
studi
measur
igg
method
prove
rid
show
higher
valu
igg
igg
low
serum
level
ig
data
unquestion
neg
effect
pediatr
conclus
moment
knowledg
suggest
also
care
interpret
low
level
one
subclass
one
hand
might
indic
transient
paraphysiolog
condit
igg
level
patient
also
rose
consider
compar
previou
treatment
averag
level
differ
determin
mg
final
children
grew
normal
height
achiev
child
rd
th
percentil
within
limit
theoret
valu
calcul
height
parent
substitut
therapi
ivig
allow
patient
return
normal
activ
consider
improv
qualiti
life
year
never
come
across
substanti
unwelcom
reaction
infecti
complic
also
found
author
ivig
could
also
effect
reduc
allerg
symptom
discuss
thu
far
presupposit
lack
block
allergen
mastocyt
fcr
thank
modest
quantiti
igg
present
prepar
addit
increas
understand
igg
transplacent
passag
chap
absolv
function
time
transfus
case
mother
antibodi
id
fetal
defens
complet
quantit
adequ
sigad
common
ivig
prepar
use
even
low
content
iga
enrich
extrem
short
iga
lifespan
would
therefor
suggest
iga
administr
everi
day
infus
iga
reach
secret
ivig
indic
defici
associ
igg
transfus
blood
deriv
becom
necessari
one
must
first
investig
serum
antibodi
antiiga
level
igg
ige
posit
avoid
infus
administ
hospit
strict
medic
supervis
use
wash
red
blood
cell
precaut
must
taken
subject
ata
ivig
appropri
administ
also
ensur
benefici
effect
qualiti
life
known
therapi
contrast
neurolog
symptom
patient
humor
defici
alongsid
ivig
appropri
antibiot
prophylaxi
suitabl
monthli
cycl
altern
amoxicillin
cephalosporin
cotrimoxazol
etc
bear
mind
famili
complianc
cvid
recurr
infect
caus
giardia
lamblia
treat
use
furazolidon
mgkgday
methronidazol
mgkgday
day
necessari
repeat
cvid
treatment
special
center
involv
recombin
il
il
cimetidin
tcell
pid
repres
sever
clinic
emerg
omenn
syndrom
hypovolem
shock
reticular
dysgenesi
imman
battl
surviv
although
precis
figur
unavail
thousand
patient
worldwid
differ
form
modest
defici
result
clear
hgg
subnorm
igg
level
inde
associ
variou
manifest
immun
dysfunct
therefor
advis
case
proceed
specif
investig
measur
respons
polysaccharid
antigen
studi
lymphocyt
activ
vitro
children
normal
serum
level
instead
lack
antibodi
respons
polysaccharid
antigen
conclus
investig
fig
studi
children
age
half
atop
half
confirm
thesi
conclud
answer
similar
group
therefor
exclud
greater
rri
predisposit
atop
children
mani
patient
high
ige
level
present
atop
manifest
thought
increas
concentr
relat
reduc
inhibit
activ
thymu
ige
synthesi
recurr
sinopulmonari
infect
must
make
one
also
consid
cystic
fibrosi
immotil
cilia
syndrom
children
malnutrit
chap
suffer
numer
id
preval
concern
cmi
vulner
make
succumb
sever
bacteri
infect
urti
often
also
risk
death
obes
subject
may
also
affect
rri
due
possibl
adipos
tissu
hypovascular
defect
granulocyt
microbicid
activ
presenc
antibodi
defici
antibiot
treatment
chosen
prevent
therapi
less
sever
case
otherwis
prefer
therapi
consist
ivig
fig
treatment
restrict
limit
number
diseas
includ
form
id
secondari
cytopen
id
effect
prove
dbpc
studi
like
posit
form
intervent
describ
appear
use
uncompl
thi
two
children
age
hige
kawasaki
diseas
administ
mgdie
ivig
day
one
hige
receiv
one
dose
ige
level
fall
uiml
day
henc
almost
normal
ige
product
symptom
relaps
month
similar
result
use
singl
dose
also
obtain
two
children
hige
sever
ad
follow
data
repres
number
clinic
immunolog
paramet
children
suffer
humor
pid
ata
igg
level
mgdl
treatment
ivig
also
higher
dosag
well
toler
patient
children
present
clear
vere
affect
sever
factor
either
hlaident
marrow
tcelldeplet
tcd
haploident
parent
marrow
standard
care
scid
fig
histocompat
relat
donor
bmt
unavail
bmt
either
hlaident
unfraction
tcd
haploident
parent
marrow
standard
care
scid
one
scid
infant
receiv
tcd
ident
haploidengenet
determin
id
given
bmt
attempt
correct
underli
id
includ
recent
seri
specif
treatment
cellular
pid
consist
bmt
hlacompat
donor
ideal
sc
donor
normal
sibl
share
ident
hla
class
class
ii
loci
without
donor
transplant
usual
result
fatal
gvhd
death
occur
eventfre
surviv
treatment
tical
bmt
first
day
life
current
aliv
period
surviv
rang
month
year
transplant
compar
favor
surviv
rate
infant
receiv
transplant
median
age
day
rang
day
girl
b
scid
receiv
full
match
bmt
sister
age
week
worldwid
survey
conduct
buckley
subsequ
addit
publish
case
literatur
reveal
patient
pid
transplant
hlaident
marrow
period
year
aliv
patient
worldwid
surviv
scid
result
success
transplant
hlaident
haploident
bm
importantli
infant
undergo
transplant
first
month
life
current
aliv
compar
cutoff
month
vs
children
younger
vs
age
month
receiv
bmt
stress
neonat
develop
higher
lymphocyt
respons
phytohemagglutinin
higher
number
cell
first
year
life
receiv
bmt
late
tcell
antigen
peak
earlier
higher
valu
neonat
bmt
day
year
late
bmt
year
past
year
scid
patient
receiv
bmt
duke
univers
medic
center
surviv
vari
age
year
bmt
hlaident
donor
other
receiv
rigor
tcd
haploident
bm
parent
often
mother
soy
lectin
srbc
roset
techniqu
use
r
buckley
per
comm
novemb
april
uncommon
bmt
treat
ar
scid
undertaken
girl
donor
hlamismatch
sister
previous
receiv
bmt
father
present
age
affect
molloscum
contagiosum
infect
bmt
hla
ident
unfraction
tcd
hla
aploident
recent
trial
found
affect
children
famili
hlaident
donor
rid
altern
therapeut
option
bmt
mud
haploident
bmt
hlamismatch
relat
donor
mmrd
children
may
find
match
donor
therefor
remain
pidaffect
children
candid
tcd
haploident
bmt
mud
hsct
success
young
children
success
rate
decreas
dramat
age
year
tabl
bmt
surviv
compar
mmrd
bmt
surviv
significantli
higher
rid
mud
hlaident
sibl
donor
unavail
phenotyp
hlamatch
unrel
bmt
need
also
use
defici
clinic
immun
outlin
normal
variabl
effect
igg
subclass
treatment
c
median
year
bmt
p
time
public
possibl
earlier
diagnosi
untreat
opportunist
infect
develop
result
improv
consider
last
two
decad
bmt
success
appli
within
first
day
life
infant
scid
still
aliv
rang
month
year
justifi
utero
transplant
complet
normal
tcell
function
obtain
within
day
patient
still
present
year
children
receiv
mismatch
parent
bmt
remain
aliv
tcell
immun
reconstitut
median
rang
month
bmt
children
receiv
allogen
bmt
first
day
life
aliv
three
five
children
receiv
hsct
aliv
well
month
breast
feed
appear
correl
earlier
reconstitut
donor
mother
intraamniot
gene
transfer
success
carri
laboratori
anim
regist
dosedepend
manner
fetal
gastroenter
respiratori
effect
confirm
human
be
method
treatment
certainli
prove
use
prenat
correct
pid
bmthsct
complet
condit
regimen
busulfan
cyclophosphamid
less
toxic
total
lymphoid
irradi
combin
nucleosid
analog
antilymphocyt
antibodi
prepar
exampl
busulfan
mgkg
melphalan
mgm
antithymocyt
globulin
mgkg
enhanc
engraft
rate
haploident
bmt
pid
recent
suggest
add
donor
peripher
sc
mobil
gcsf
mgkg
day
bm
cell
procedur
cell
load
increas
allow
intensif
condit
regimen
induct
faster
engraft
utero
bmt
suggest
advantag
includ
steril
environ
utero
immatur
fetal
immun
system
enabl
prevent
clinic
manifest
diseas
neonat
engraft
without
use
cytotox
condit
regimen
child
thu
treat
well
age
month
two
seri
six
four
patient
two
addit
case
report
utero
transplant
publish
yet
failur
bcell
engraft
function
may
result
longterm
depend
ivig
replac
better
result
publish
utero
bmt
scid
implicit
infant
admit
diagnos
median
age
day
fh
previous
affect
infant
bmt
success
children
aliv
well
followup
year
day
vs
approxim
month
howev
suggest
utero
transplant
may
carri
risk
associ
inject
fetu
inabl
detect
gvhd
gestat
umbil
cb
transplant
ucbt
done
two
children
affect
defici
omennlik
syndrom
aliv
well
year
ucbt
unrel
ucbt
eight
children
sever
tcell
id
three
result
consist
stabl
b
nk
cell
develop
faster
avail
ucbt
meaning
advantag
patient
requir
urgent
transplant
median
day
rapidli
receiv
bone
marrow
larg
report
patient
scid
seven
unspecifi
pid
receiv
unrel
ucbt
ucb
evalu
sc
sourc
immun
reconstitut
children
sever
primari
tcell
id
scid
reticular
dysgenesi
thymic
dysplasia
cid
dg
match
sibl
donor
unavail
use
date
patient
three
infant
reject
tcdmismatch
parent
bmt
without
prior
cytoreduct
engraft
infus
ucbt
girl
hla
class
ii
defici
success
relat
ucbt
graft
failur
follow
tcd
nonident
bmt
girl
reticular
dysgenesi
fail
engraft
follow
first
transplant
fulli
engraft
second
unrel
ucbt
five
six
patient
show
grade
gvhd
although
one
child
experienc
grade
iv
skin
gut
gvhd
immunolog
ucbt
result
consist
stabl
tcell
bcell
nkcell
develop
longterm
eventfre
surviv
month
recoveri
antigenspecif
respons
report
follow
unrel
ucbt
child
omenn
syndrom
gene
therapi
revolution
could
revolution
even
pid
treatment
near
futur
analyz
tabl
requisit
appli
form
genet
engin
treatment
respons
gene
must
clone
common
techniqu
involv
knockout
mice
inactiv
particl
employ
retrovir
vector
tabl
total
depriv
genom
factor
except
normal
copi
gene
insert
indispens
allow
vector
reach
human
nucleu
integr
cellular
genom
case
pbl
collect
leukapheresi
cultiv
vitro
retrovir
particl
contain
normal
gene
rna
copi
thu
healthi
gene
introduc
cell
genom
use
vector
manipul
cell
reinfus
restor
normal
immun
function
system
use
treat
two
children
age
month
suffer
scid
ada
defici
employ
autolog
pbl
bm
cell
cb
cell
three
report
success
gene
therapi
infant
xlink
scid
b
scid
major
step
forward
among
repeat
effort
achiev
better
immun
reconstitut
adascid
gene
therapi
bmtsct
immedi
diagnosi
made
two
capac
wildtyp
replicationcompet
retrovirus
caus
leukemia
immunolog
immatur
neonat
mice
human
two
children
retrovirus
caus
insert
oncogenesi
longknown
potenti
complic
retrovir
gene
transfer
attempt
gene
integr
occur
random
genom
thu
deregul
express
cellular
oncogen
complic
thought
unlik
vector
capabl
insert
cell
chromosom
repeatedli
reproduc
integr
lentivirus
may
effect
murin
retrovirus
gene
transfer
human
hematopoiet
sc
lymphocyt
adascid
safeti
efficaci
hsc
gene
therapi
combin
nonmyeloabl
condit
treatment
scid
allow
two
children
live
home
clinic
well
normal
growth
develop
januari
fda
place
clinic
hold
activ
gene
therapi
trial
use
retrovir
vector
insert
gene
blood
sc
learn
second
child
treat
french
gene
therapi
trial
develop
leukemialik
condit
gene
therapi
hold
despit
enorm
promis
certain
scid
cid
variant
surviv
scid
european
experi
unfraction
hlaident
tcd
nontcd
haploident
mud
bmt
patient
scid
report
surviv
sustain
engraft
significantli
better
hlaident
mismatch
transplant
vs
within
hlaident
group
surviv
bmt
genotyp
phenotyp
ident
relat
mud
respect
nonscid
surviv
genotyp
hlamatch
phenotyp
hlamatch
mmrd
mud
bmt
respect
retrospect
analysi
bmt
perform
european
center
children
young
month
differ
pid
exclud
scid
overal
surviv
among
recipi
hla
genet
ident
bmt
patient
receiv
close
match
bmt
recipi
bmt
two
three
mismatch
hla
antigen
signific
improv
surviv
achiev
pid
overal
surviv
vs
primarili
decreas
frequenc
infecti
complic
similar
analysi
perform
children
scid
european
center
patient
aliv
evid
engraft
month
bmt
howev
patient
die
month
postbmt
mainli
due
cgvhd
viral
infect
thu
gvhd
month
bmt
b
scid
vs
b
scid
main
factor
associ
poor
outcom
diseasefre
surviv
significantli
better
patient
b
scid
b
scid
children
age
month
includ
novel
splice
imit
common
gc
chain
haploident
peripher
progenitor
cell
mobil
gmcsf
isol
puriti
cell
infus
prior
chemoabl
prophylaxi
gvhd
children
show
sign
tcell
reconstitut
begin
week
infus
wean
continu
cure
excel
health
without
gvhd
month
transplant
one
child
need
replac
ig
receiv
booster
infus
sc
origin
donor
year
later
improv
bcell
function
receiv
ig
everi
month
follow
month
gene
transfer
howev
retrovir
vector
treatment
data
ciita
class
ii
transactiv
cgd
chronic
granulomat
diseas
xla
x
link
agammaglobulinemia
abbrevi
see
tabl
done
success
see
text
detail
b
utero
transplant
matern
stem
cell
trial
children
pid
receiv
bm
hlanonident
relat
donor
hlaident
unrel
donor
european
center
august
june
children
surviv
month
bm
tcd
use
either
erythrocyt
roset
monoclon
antibodi
prevent
gvhd
addit
surviv
rate
report
previous
tabl
seri
consecut
ud
bmt
children
scid
nonscid
pid
receiv
bmt
reducedintens
condit
ric
regimen
surviv
followup
well
children
receiv
bmt
myeloabl
condit
mat
surviv
followup
therefor
ric
regimen
result
improv
surviv
reduc
bmtrelat
mortal
compar
mat
hr
children
undergo
ud
bmt
transplant
patient
probabl
surviv
differ
accord
donor
type
hlaident
sibl
donor
relat
donor
mud
significantli
boy
receiv
mud
transplant
year
age
surviv
rate
similar
receiv
hlaident
sibl
transplant
howev
time
requir
develop
immun
function
haploident
sct
quit
differ
unfraction
hlaident
bm
lymphocyt
matur
tcell
phenotyp
function
fail
rise
significantli
month
bmt
normal
tcell
function
reach
month
bcell
function
develop
much
slowli
averag
year
normal
mani
bcell
function
despit
normal
tcell
function
ex
vivo
rigor
deplet
postthym
cell
donor
marrow
caus
gvhd
effici
feasibl
even
haploident
set
presum
effect
infectioncontrol
measur
better
transplant
strategi
nonscid
sct
provid
cure
graft
unrel
donor
almost
benefici
genet
hlaident
rel
patient
defici
bcell
function
persist
transplant
requir
lifelong
ivig
therapi
necessari
prevent
bacteri
common
viral
infect
patient
also
persist
defici
tcell
function
sct
children
rri
depend
natur
infect
pediatrician
prescrib
appropri
symptomat
andor
antibiot
therapi
presenc
persist
inflamm
winter
risk
close
acut
recurr
episod
higher
antiinflammatori
prepar
prescrib
via
aerosol
chromon
ketotifen
b
adrenerg
necessari
steroid
topic
use
strictli
depend
need
suggest
monitor
measur
keep
clinic
diari
acut
episod
briefli
note
continu
registr
clinic
symptom
regress
least
day
return
keep
note
diari
time
cough
andor
nasal
andor
bronchial
inflamm
complet
pef
well
respiratori
paramet
right
begin
everi
month
obviou
medic
intervent
resolut
center
special
infantil
respiratori
physiopatholog
contact
children
sar
treat
highdos
ribavirin
oral
prednisolon
iv
methylprednisolon
shortterm
advers
effect
antibiot
must
use
care
children
influenc
posit
neg
innat
cellular
humor
immun
chap
interact
il
growth
factor
known
repeat
use
often
caus
phenomena
involv
allergi
intoler
infectionpron
children
suffer
vri
given
antibiot
unnecessarili
italian
children
male
age
month
year
median
year
histori
rri
macrolid
therapi
acut
respiratori
infect
influenc
natur
histori
rri
probabl
elect
activ
atyp
bacteria
consid
emerg
antibioticresist
bacteri
stock
exampl
pneumonia
immunotherapi
propos
mean
prevent
rri
provid
children
small
dose
inact
bacteri
antigen
liabl
trigger
specif
protect
immun
respons
tabl
exampl
bv
significantli
reduc
urti
rate
particularli
dbpc
studi
children
age
histori
acut
urti
activ
prevent
rri
episod
meaning
reduct
number
day
suffer
acut
urti
bacteri
ribosom
membran
proteoglycan
pneumonia
stimul
b
cell
secretori
respons
well
memori
cell
may
use
respond
futur
infect
ribosom
immunotherapi
appear
well
toler
also
ideal
target
induc
mucos
respons
among
prepar
reserv
specif
use
studi
pidotimod
dbpc
trial
prove
effect
sampl
children
rri
also
show
increas
absent
placebotr
children
use
immunostimul
limit
children
proven
high
suscept
acut
urti
overexpos
children
attend
daycar
facil
attend
kindergarten
elementari
school
howev
accord
metaanalysi
immunostimul
effect
treatment
prevent
acut
urti
children
furthermor
indiscrimin
pure
empir
use
ivig
must
discourag
everi
child
rri
wherea
prospect
dbpc
studi
ivig
cotrimoxazol
children
year
refer
recurr
bacteri
rri
becam
infectionfre
obserif
caus
pneumococci
kind
vaccin
provid
disappoint
result
fig
indic
immun
base
specif
immun
possibl
specif
intervent
children
pid
one
bear
mind
aforement
fact
past
year
busi
motion
fundament
problem
underli
major
condit
mani
map
specif
chromosom
locat
impress
number
vation
period
addit
extrem
unfavor
costbenefit
ratio
immun
children
rri
defici
antibodi
respons
germ
express
capsular
polysaccharid
success
vaccin
avoid
administr
live
viru
vaccin
integr
necessari
igg
replac
therapi
furthermor
view
avail
conjug
vaccin
possibl
induc
antipneumococcusigg
provid
effect
treatment
children
rri
especi
treatment
fundament
biolog
error
identifi
pediatrician
entrust
difficult
job
identifi
earli
possibl
possibl
exist
pid
rememb
suggest
case
histori
chap
except
clinic
emerg
omenn
syndrom
reticular
dysgenesi
specif
research
becom
necess
thank
new
diagnost
therapeut
advanc
conceiv
past
year
earlier
one
act
one
hand
prenat
diagnosi
bmt
sct
therapi
greater
chanc
increas
life
expect
children
addit
ensur
better
qualiti
life
discoveri
clone
gene
diseas
obviou
implic
potenti
gene
therapi
rapid
advanc
suggest
soon
mani
come
one
common
differenti
diagnos
occur
child
affect
rri
believ
number
infect
must
immedi
clarifi
although
evalu
accord
differ
numer
epidemiolog
factor
associ
instead
concern
sever
site
infect
well
type
pathogen
agent
character
children
pid
howev
antibiot
ban
support
hygien
hypothesi
chap
